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Pu b l ic  Health  Surveillance  Ap p l ie d  t o  Re p r o d u c t iv e  Health
Le a r n in g  Ob je c t iv e s
This module is designed for reproductive health professionals who are 
interested in conducting and evaluating reproductive health surveil­
lance systems and who need a working knowledge of surveillance in 
reproductive health.
After studying the material in this module, the student should be 
able to:
• Define public health surveillance and its components.
• State the goals o f public health surveillance.
• List general principles of public health surveillance.
• List the main uses of surveillance data.
• Describe sources o f data that can be used for reproductive health 
surveillance.
• Describe methods and systems useful for conducting reproductive 
health surveillance.
• Perform basic analysis o f surveillance data.
• Discuss the steps in the evaluation of a surveillance system.
• List the various attributes o f surveillance systems.
• Describe how surveillance data are linked to public health action.
• Describe how to link health program objectives and indicators to 
surveillance.
• Use a surveillance grid to plan a reproductive health surveillance 
system.
• List examples of surveillance systems specific to reproductive health.
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Case Study: Increase in Cases of Congenital Syphilis 
Baltimore, 1993-1996
Between 1993 and 1996, surveillance of congenital syphilis (CS) in the city of Baltimore revealed an increase from 62 to 282 
cases per 100,000 live-born infants. Because of this dramatic 
increase, public health officials assessed the magnitude of the 
syphilis epidemic in pregnant women in Baltimore and tried to 
identify ways to increase CS prevention. An assessment of the 
surveillance system, along with a review of hospital discharge 
records, yielded the following information:
• All cases of CS found through hospital discharge had also 
been reported to the CS surveillance system, confirming the 
completeness of the surveillance system.
• Among 90 women with active syphilis during pregnancy,
62 (69%) delivered infants with CS; 28 (31%) of the infants 
did not have CS.
• Mothers of infants with CS and mothers of infants without CS 
had similar demographic characteristics (age, race, marital status).
• Mothers of infants with CS were more likely to have had a 
third-trimester diagnosis of syphilis, no prenatal care or prenatal 
care initiated late in the third trimester, and missed opportunities 
for screening and prenatal care (e.g., spent time in jail or had 
contact with a social worker or other social service agency).
In response to these findings, public health officials
• Alerted prenatal care and other health providers to initiate 
syphilis screening and treatment programs for women of 
reproductive age.
• Initiated a rapid screening and treatment program for detained 
and arrested women.
• Worked to amend an existing law on syphilis testing during 
pregnancy to require syphilis testing at 28 weeks gestation or 
the first visit thereafter to ensure diagnosis in time to prevent 
prenatal transmission.
Continued surveillance of CS will allow Baltimore health officials 
to evaluate the effects of these interventions.
A d ap ted  from : C D C . Ep idem ic o f  congenital syphilis— Baltim ore, 1 9 9 6 -1 9 9 7 .
M M W R  l9 9 8 ;4 7 (4 2 ) :9 0 4 - 7 .
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In t r o d u c t io n  t o  Pu b l ic  H e a l t h  
Su r v e il l a n c e
Public health surveillance began centuries ago with the close observa­
tion o f individuals who had been exposed to a communicable disease, 
in order to detect early symptoms and implement prompt isolation 
and control measures. This process is now referred to as medical or 
personal surveillance (1). By comparison, public health surveillance is 
a term used today to describe the process o f closely observing health 
events in populations, with a direct and established link to public 
health action. Over the last 40 years the uses and practices o f surveil­
lance have evolved dramatically— surveillance has come to include 
infection control efforts as well as the monitoring of a wide variety 
of health events, such as acute and chronic diseases, injuries, environ­
mental and occupational hazards, behavioral risk factors, and repro­
ductive health. Some examples of questions about diseases or other 
health events that surveillance can be used to answer include the 
following (2):
• W hat are currently the most serious health problems?
• W hat are the emerging health problems?
• Can these problems be prevented?
• How effective and costly are various prevention and control 
strategies?
• W hich prevention and control strategies should be implemented?
• W hat impact do alternative prevention and control strategies have 
on health outcomes?
• Do prevention and control strategies need to be modified so pro­
gram objectives can be met?
• How should scarce economic, material, and human resources be 
allocated and targeted in order to achieve health goals?
In 1992, the U.S. Centers for Disease Control and Prevention (CDC) 
convened the International Symposium on Public Health Surveil­
lance, during which surveillance was advocated as an essential part of 
the global health agenda (2). The symposium focused on the use of 
surveillance for setting priorities, policy development and program 
evaluation, effective communication o f surveillance information, and 
the need for capacity building. Surveillance and monitoring of health 
events are also included among the essential public health functions 
ranked by the World Health Organization (W HO) (3).
W H O  Study of 
Essential Public 
Health Functions 
(rank out of 37)
1. Immunization
2. Monitoring of 
morbidity and 
mortality
3. Disease outbreak 
control
4. Disease surveillance







Sou rce : B e ttcher DW , Sapirie S,
Goon E H . Essen tia l public health
functions: results o f  the
international D elphi study.W orld
H ea lth  S ta t Q 1 9 9 4 ;5 1 :4 4 -5 4 .
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D efinition o f Public Health Surveillance
Public health surveillance is the “ongoing systematic collection, 
analysis, interpretation of data (e.g., regarding agent/hazard, risk 
factor, exposure, health event) essential to the planning, implementa­
tion, and evaluation of public health practice, closely integrated with 
the timely dissemination of these data to those responsible for preven­
tion and control” (4). This definition highlights the essential features 
of surveillance systems, which are the systematic and ongoing collec­
tion, analysis, interpretation, and dissemination of data that lead to 
action and a link with public health practice.
Surveillance systems depend on networks of people and activities 
to maintain the flow of information and may function at a range 
of levels, from local to international. Surveillance systems are 
often considered information loops or cycles involving health care 
providers, public health agencies, and the public (1). Public health 
surveillance systems are used to collect descriptive data that identify 
characteristics o f person, place, and time regarding the particular 
health event under surveillance. In contrast to one-time surveys or 
epidemiologic studies, surveillance is a process that continues over 
time. Sometimes, repeated surveys are used to detect trends in the 
data. Importantly, a surveillance system is not complete without 
feedback components and a direct link to public health action.
The essential link between public health surveillance data and public 
health action is the application of these surveillance data to health 
promotion and disease prevention. Individuals and groups who have 
the resources to undertake effective prevention and control activities 
in response to the information provided by the surveillance system 
need to be included in the dissemination and communication of 
results from the surveillance system. Health care providers, health 
agencies, and the public are all responsible for disease prevention 
and control, and therefore should receive feedback of surveillance 
information (2). Table 1 illustrates the link between surveillance 
and public health action for decision making.
Table 1. The Com ponents o f  Surveillance and Resulting Public Health Action  
Public Health Surveillance Action
Surveillance











Adapted from: Principles o f epidemiology: an introduction to applied epidemiology and biostatistics. Atlanta (GA): 
Centers for Disease Control and Prevention; 1992. p. 291.
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Principles o f Surveillance
An effective surveillance system:
• Addresses health events that are of considerable public health 
importance; in other words, health events that cause a substantial 
amount of morbidity and/or mortality and are amenable to 
practical control or prevention measures.
• Responds to clearly defined objectives.
• Identifies and correctly classifies a large proportion of target 
health events.
• Correctly reflects the distribution o f events over time, place, 
and person.
• Includes the following components: 1) a clear definition of the 
health event(s) under surveillance; 2) a clear and logical path for 
data flow; 3) an adequate knowledge of the population under 
surveillance; and 4) well-defined and appropriate methods for 
collection, analysis, interpretation, and feedback o f information.
• Results in meaningful and effective public health action based 
on the data obtained from the system.
• Consists of a simple, flexible, and responsive architecture.
• Promotes a high level of participation of all those involved in 
the system.
• Provides information in a timely manner so as to enhance relevant 
public health action.
• Requires justifiable resources to establish and maintain.
An effective surveillance system allows for the integration of epide­
miologic, behavioral, laboratory, demographic, and other types of 
data to provide the information needed by those who must take 
action (2).
Ethics o f Public Health Surveillance
As with all public health activities, practitioners must address the 
ethical issues associated with surveillance activities. In particular, 
issues of privacy, confidentiality, and potential need for informed 
consent are important to resolve when designing a surveillance 
system. Finally, a surveillance system that only collects data but 
does not facilitate the use of that data for public health action can 
be considered an unethical system because it wastes valuable public 
health resources with no benefit to the public.
5
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In addition to complying with any regulations of the country or
institution that is implementing the surveillance system, the following
questions can be helpful in addressing ethical issues related to surveil­
lance systems (5):
1. Can you justify the surveillance system in terms of maximizing 
potential public health benefits and minimizing harm to the 
public and individuals?
2. Can you justify the use of any identifiers and the maintenance of 
records with identifiers?
3. Should you elicit informed consent from potential surveillance 
subjects?
4. Can confidentiality of information collected from individuals 
be ensured?
5. Have the surveillance protocols been reviewed by colleagues and 
outside experts?
6. Do you have a plan for sharing data and findings with colleagues, 
clinicians, the public health community, and the general public?
7. Do you have a plan for ensuring that the surveillance findings lead 
to action— change practice, target resources and interventions, 
monitor trends over time, and stimulate other activities to improve 
the public’s health?
6
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Pu b l ic  He a l t h  Su r v e il l a n c e  Ap p l ie d  
t o  Re p r o d u c t iv e  H e a l t h
Reproductive health surveillance can be defined as “a component 
of the health information system that permits the identification, 
notification, quantification, and determination of events of reproduc­
tive health significance for a defined period of time and specified 
geographic location(s), with the goal of orienting appropriate public 
health measures for disease prevention and health promotion” (7).
The goal of reproductive health surveillance is to identify or examine 
ongoing patterns of health events so as to effectively investigate and 
control the public health events in question, and to prevent morbidity 
and mortality in a population. Surveillance data are used both to 
determine the need for public health action and to assess the effec­
tiveness of programs. Reproductive health events that can be tracked 
through a surveillance system include, but are not limited to:
• Vital statistics (births and fetal deaths).
• Deaths and ill health due to pregnancy (maternal mortality and 
morbidity) and other pregnancy-related events.
• Infant deaths and ill health.
• Sexually transmitted diseases.
• “Risky” behaviors before or during pregnancy.
• Contraceptive practices.
• Unintended pregnancy.
• Indicators of health services such as prenatal care.
W H O  Definition of 
Reproductive Health
The World Health 
Organization (WHO) 
defines reproductive
health as a condition in 
which the reproductive 
process is accomplished 
in a state of complete 
physical, mental, and 
social well-being, and is 
not merely the absence 
of disease or disorders of 
the reproductive system.
It involves the interaction 
of four main components: 
1) the ability, particularly 
of women, to regulate and 
control fertility; 2) safe 
motherhood; 3) infant 
and child survival, growth, 
and development; and 
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Uses o f  Su r v e il l a n c e  Da t a
Surveillance data are used to monitor health events to 
determine the need for public health action and to evaluate 
the effectiveness of programs. It is crucial to understand the 
uses o f surveillance data, their application in decision-making, 
and their role in identifying research opportunities. Officials 
responsible for the health of the population are dependent 
on surveillance data because o f the focus on providing 
information for public health action and a mechanism to 
evaluate control and prevention programs.
Surveillance data can be used for the following:
Identify the Health Status o f a Population
• Identify new syndromes and infectious agents. New syndromes 
have been identified from the reporting, analysis, and interpre­
tation o f descriptive surveillance data. For example, researchers 
noticed unique clinical presentations and characteristics of the 
sentinel cases of acquired immune deficiency syndrome (AIDS) 
that suggested a possible connection between these cases. All 
the AIDS patients who were seen at the University of California 
at Los Angeles (UCLA) Medical Center in 1981 suffered from 
the same rare opportunistic infections (8). The UCLA physicians 
played a crucial role in detecting the presence o f a new disease
in their community by characterizing the unusual pattern of 
disease occurrence by person, place, and time.
• Estimate the magnitude o f a health problem. Surveillance data 
are used to quantify the magnitude o f a health problem or the 
burden of disease due to a specific cause. These estimates can 
be used as baseline figures to prioritize public health problems. 
Table 2 shows estimates of maternal mortality globally and 
highlights the discrepancies in the magnitude of maternal 
mortality between more developed and less developed regions 
o f the world.
• Determine geographic distribution. By pinpointing geographic 
areas of higher prevalence of the health outcome of interest, 
prevention and control resources can be more efficiently
9
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Table 2. Estimates o f  Maternal M ortality
UN Region Maternal M ortality Ratio 




Lifetime Risk of 
Maternal Death, 
1 in:*
W orld ............................................................................ 430 585,000 60
More developed regionsf .............. ............................. 27 4,000 1,800
Less developed regions .................. ..........................  480 582,000 48
Africa .................................................. ..........................  870 235,000 16
Eastern Africa ................................ ........................1,060 97,000 12
M iddle Africa ................................ ........................... 950 31,000 14
N orthern Africa ............................ ........................... 340 16,000 55
Southern Africa ............................ ..........................  260 3,600 75
Western Africa ............................... ........................1,020 87,000 12
Asiaf ......................................... ..........................  390 323,000 65
Eastern Asia .................................... ............................. 95 24,000 410
South-central Asia ........................ ..........................  560 227,000 35
South-eastern Asia ........................ ..........................  440 56,000 55
Western Asia ................................... ..........................  320 16,000 55
Europe ................................................ ............................. 36 3,200 1,400
Eastern Europe .............................. ............................. 62 2,500 730
Northern Europe .......................... ............................. 11 140 4,000
Southern Europe .......................... ............................. 14 220 4,000
Western Europe .......................................................... 17 350 3,200
Latin America and the Caribbean .......................... 190 23,000 130
Caribbean ....................................... ..........................  400 3,200 75
Central America ........................... ........................... 140 4,700 170
South America ............................... ..........................  200 15,000 140
N orthern America .......................... ............................. 11 500 3,700
Oceaniaf ............................................ ..........................  680 1,400 26
Australia-New Zealand .............. ............................. 10 40 3,600
Melanesia .................................................................... 810 1,400 21
Source: D ata from World Health Organization. W H O  revised 1990 estimates o f maternal mortality: a new approach 
by W H O  and UNICEF. Geneva, Switzerland: World Health Organization; 1996. p. 1—15.
*Lifetime risk of maternal death reflects the chances o f a woman’s dying from maternal causes over her reproductive life 
span, usually given as 30—35 years.
Australia, New Zealand, and Japan have been excluded from the regional totals, bu t are included in the total for more 
developed regions.
targeted. Geographic patterns may also generate hypotheses 
about disease etiology and spread (Figure 1).
• Identify groups at high risk for a health event o f interest. This infor­
mation is vital for prioritizing health interventions and allocating 
resources. For example, the Pregnancy Risk Assessment M onitor­
ing System (PRAMS), supported by CDC, compiles data on 
maternal and child health indicators of health events that occur 
before, during, and after pregnancy among women who deliver a
10
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live-born infant (9). These data 
can be used by policy makers to 
assess the status o f public health 
programs in preventing high-risk 
pregnancies and adverse preg­
nancy outcomes. Another ex­
ample comes from C D C ’s Preg­
nancy-Related Mortality Ratio 
(Figure 2). The figure highlights 
the increased mortality rates 
among older women and among 
black women compared with 
white women.
M onitor Trends in 
Health Outcomes
• Identify changes in the occurrence 
and distribution o f disease to 
guide immediate action for cases 
o f public health importance. This 
is especially important at the 
local level, in the event of an 
epidemic or an outbreak. For 
example, the case study in the 
introduction (p. 2) illustrates the 
confirmation of an increase in 
cases o f congenital syphilis by 
the assessment of surveillance.
• Identify changes in infectious 
agents and host factors to assess 
the potential for future disease 
occurrence, and to anticipate 
changes in the natural history of 
a disease. For example, increases 
in antibiotic-resistant gonorrhea 
were detected in the United 
States in the 1980s. Surveillance 
enabled public health officials 
to monitor the spread of this 
strain. Surveillance data facili­
tated treatment and prevention 
activities, indicating the need 
for modifications to local
Figure 1. Population-Based Prevalence o f  Perinatal 
Exposure to Cocaine— Georgia, 1994
Source: C D C . Population-based prevalence o f perinatal exposure to 
cocaine— Georgia, 1994. M M W R  1996;45(41):887—91. Mary D. 
Brantley, M PH , M T  (ASCP) SI, Centers for Disease Control and 
Prevention, written communication, March 2001.
Figure 2. Pregnancy-Related M ortality Ratio,* 
by Age Group and Race— United States, 1987—1990
ITS 1
ISC 
I2S -  
ICC -  




"<20 2C-24 2S-29 3C-34 3S-39
Age Group (Years)
>4Q
• A ll Races W hite ---------------Black
*Pregnancy-related deaths per 100,000 live births. 
Source: M M W R  1997;46(SS-4):17-36.
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guidelines when the proportions 
of gonococcal strains that met 
criteria for antimicrobial resis­
tance were greater than or equal 
to 1% for two consecutive 
months (10).
• Determine the etiology and 
natural history o f a disease by 
following long-term trends 
and patterns in populations.
The identification o f changes 
in long-term trends is useful 
information for public health 
decision makers who need to 
target strategies and anticipate 
needs.
Evaluate Public Health 
Action
• Guide the planning, implemen­
tation, and evaluation of
programs to prevent and control disease, injury, or adverse exposure. 
National rates of gonorrhea for the United States from 1970 
through 1998 (Figure 3) indicate that U.S. gonorrhea rates were 
dropping and were on target to meet national objectives for the 
year 2000.
• Detect the impact o f changes in health care practices and public policy. 
Data for several maternal health care indicators over time (Table 
3) indicate an improvement in maternal health care practices, 
perhaps due to changes in health care policy in Honduras during 
this time period.
Set Public Health Priorities
• Allocate public health resources. Hemorrhage is the leading cause 
o f maternal deaths in Honduras and the proportion o f maternal 
deaths due to hemorrhage increased between 1990 and 1997 
(Figure 4). One strategy for reducing maternal mortality in this 
setting would be to provide additional resources to reduce the 
deaths caused by hemorrhage; for example, by upgrading hospital 
blood transfusion capabilities or by increasing emergency transpor­
tation services.
• Project future needs. Surveillance data can be used to project future 
needs, for increasing, decreasing, and stabilizing the need for
Figure 3. Reported Gonorrhea Rates* and 2000  
National Health Objective for Gonorrhea, by Year—  
United States, 1970—1998
500 -












2000 Objective \  —1
0
1970 1974 1978 1982 1986 1990 1994 1998
Year
*Per 100,000 population.
Source: M M W R  2000;49:538-542.
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Table 3. Maternal Health Indicators: Honduras, 1987—2001
1987 1992 1996 2001
Any prenatal care
in a health facility ............................................ ................................. 65% 73% 83% 85.4%
> 3 PN C  visits ................................................. ................................... — 51% 67% —
Births in a health facility ............................... .................................  41% 46% 54% 54%
Cesarean sections ............................................ ................................ 5.6% 6.4% 6.3% 9.6%
Adapted from: Honduras Ministerio de Salud. Encuesta nacionale de epidemiologia y salud familiar 1996. Honduras: 
M inisterio de Salud; 1997.
2001 data from: Richard M onteith, Centers for Disease Control and Prevention, written communication, M arch 2002.
Figure 4. Comparison o f  Causes o f  Maternal Death, Honduras, 1990 and 1997
1990 (N = 314) I997 (N = I92)
Hemorrhage 40%
Hypert.
Source: Melendez JH , Ochoa Vasquez JC, Villanueva Y. Investigación sobre m ortalidad materna y de mujeres en 
edad reproductiva en Honduras. Honduras: Ministerio de Salud; 1999.
resources. For example, infant and fetal deaths due to congenital 
syphilis may be decreasing. Although constant vigilance and re­
sources are needed to screen and treat pregnant women, the re­
sources associated with treating infants with congenital syphilis will 
decrease. At the same time, perhaps, infant deaths due to other 
causes may still be high, and resources can now be diverted to new 
interventions to prevent other causes o f infant mortality.
13
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Provide the Basis for Epidemiological Research
• Generate hypotheses and stimulate research. Because surveillance data 
describe a current health situation or changes in the health situation 
over time, these data can be used to generate hypotheses about the 
causes and predictors of disease. For example, one can hypothesize 
that the high proportion o f maternal deaths in Honduras due to 
hemorrhage might be related to health care services for blood 
transfusions: women may have difficulty accessing these services 
because o f lack o f emergency transportation, blood may not be 
readily available, the time it takes to begin the transfusion may be 
too long, and the health care system may have other problems.
From these hypotheses, an analytic study can be designed to iden­
tify the specific causes and predictors o f maternal deaths due to 
hemorrhage, and appropriate interventions can be implemented.
14
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So u r c e s  o f  Da t a  f o r  Pu b l ic  
H e a l t h  Su r v e il l a n c e
In many instances, analysis of routinely collected data will provide 
the basis for assessing the public health impact o f a particular health 
event. Routinely collected data provide several sources from which 
information can be obtained for public health surveillance applied to 
reproductive health issues. The selection and appropriate use of data 
from these sources depend primarily on the nature and scope of 
activities to be monitored.
Vital Statistics
The vital statistics of birth, death, marriage, and divorce are collected 
routinely in some countries and are a cornerstone of surveillance in 
both developed and developing countries (11). However, medically 
certified information on deaths is available only for less than 30% of 
the 50.5 million deaths that occur every year (12). Vital statistics are 
particularly important since, in many countries, they are the only 
form of health-related data available in a standard format and, thus, 
can be useful for global comparisons. Uses of vital statistics include 
the following:
• Monitoring long-term trends.
• Identifying differences in health status within racial or other popu­
lation subgroups.
• Assessing differences by geographic area or by occupation.
• Monitoring illnesses and deaths that are considered preventable.
• Conducting health-planning activities.
• Generating hypotheses regarding etiology or correlates of disease.
• Monitoring progress toward achieving improvements in the health 
o f the population.
Although the usefulness o f vital statistics in surveillance varies by 
health event, in general, vital statistics are more useful for conditions 
that are easily recognized at the time of birth or death. Mortality rates 
derived from vital records will most closely approximate the true 
incidence for easily diagnosed conditions with a short clinical course, 
and for conditions that are usually fatal.
In the United States, certain states include additional information 
on perinatal risk factors on their birth certificates as a way to improve 
surveillance for perinatal events. Birth certificate information can be 
used, for example, to determine the extent to which women in the
15
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United States received delayed prenatal care or no prenatal care.
Some states link information from infant death certificates with 
maternal characteristics such as age, health status, and race for the 
surveillance o f adverse reproductive health outcomes. Collection o f 
this additional information in turn supports health planning and 
targeting of services (11).
The quality of vital statistics data depends on several factors, 
including the completeness of vital registration, the accuracy of 
data provided on certificates, and the translation of information 
into computerized data. Registered events tend to differ from those 
that are not registered. For example, deaths of women in urban areas 
or who have received better medical care are more likely to be regis­
tered than are deaths among women in rural areas or among those 
who have not received medical care (7). Furthermore, delays in the 
production of final vital statistics at a national level are common, 
even though birth and death certificates are filed shortly after the 
event occurs. Death certificates cannot provide accurate information 
on the impact of diseases with low case-fatality rates or long latency 
periods. Despite these limitations, vital records serve an important 
function in providing information for surveillance of a wide range 
of health events at local, national, and international levels. Routine 
analysis o f data obtained at birth and death may point to areas in 
need of further investigation.
M orbidity Data
Morbidity data, or data on diseases and other health events, are 
obtained from several sources, including notifiable disease reports, 
hospital data, outpatient and special clinics data, and laboratory 
data. Registries are another valuable source o f health data.
Notifiable disease reports. Health care providers are required to report 
certain health events occurring within a geopolitical boundary 
(county, state, province, etc.). Requirements to report health events 
vary from place to place, depending on health priorities and policies. 
In general, a disease is designated as notifiable when the link between 
case report and public health action is clear (i.e., the report o f a case 
of the health event under surveillance leads the health authorities 
to take certain measures) (13). Sexually transmitted diseases such as 
chancroid, gonorrhea, syphilis, HIV infection, and AIDS are required 
to be reported by law in many places. In some areas, abortions and 
maternal deaths are included in the list of reportable events.
In general, persons obligated to report known or suspected notifiable 
conditions include physicians, dentists, nurses, and other health
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professionals, medical examiners, and administrators of hospitals, 
clinics, nursing homes, schools, and nurseries. In some cases, labora­
tories and the general public are required to report notifiable diseases. 
These reports are routinely used by health agencies at all levels for 
public health surveillance— local, national, and global.
Hospital data. Many hospitals maintain discharge records for adminis­
trative and financial purposes. Local and national surveillance systems 
can make use of these data by collecting information from samples of 
hospitals for surveillance of a wide range of pregnancy-related events, 
including birth defects, infant deaths, unintended pregnancy, and 
maternal morbidity and deaths. Pertinent information available 
through hospital records may include demographic information, 
diagnoses, length of hospital stay, outcome, and other patient 
information that can be reported without identifying individuals. 
Along with information on burden of disease, this information 
may also provide important data on health activities.
A disadvantage of using hospital data is that they are facility-based 
and, thus, population-based rates usually cannot be estimated. 
Hospital data are most useful for conditions or procedures for 
which patients are typically hospitalized, for example, cesarean 
sections, but less so for conditions for which many patients are 
treated outside a hospital setting, for example, pelvic inflammatory 
disease. Another disadvantage is that fee-for-service hospitals or ones 
that serve patients with a certain type o f insurance may admit mainly 
economically advantaged people. Such hospitals may have lower rates 
of severe illnesses or deaths than the rest of the community. Hence, 
rates derived from hospital data must be interpreted with caution 
before they can be generalized to the overall population.
Outpatient and special clinics data. Information from special 
outpatient clinics can be especially useful in reproductive health 
surveillance of sexually transmitted diseases (STDs) and pregnancy- 
related outcomes. Outpatient data also are facility-based and thus 
usually cannot be generalized to the population.
Laboratory data. Laboratories can be a useful source of surveillance 
data in reproductive health epidemiology, especially for diseases 
in which laboratory confirmation is essential for diagnosis (e.g., 
confirmation o f HIV infection). Laboratory-based surveillance is an 
important component o f the prevention and control of reproductive 
tract infections (RTIs). The traditional approach to diagnosis and 
treatment of RTIs is through laboratory diagnosis to determine the 
etiologic agent causing infection. In developed countries, laboratory
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tests are used to confirm symptomatic infections, as well as detect 
asymptomatic infections, and thus provide data for epidemiological 
surveillance and monitoring o f disease sensitivity to antibiotic treat­
ment (antibiotic resistance).
Registries
A registry serves as a listing of all occurrences of a disease or category 
of disease (such as cancer, birth defects, or immunization) within 
a defined area (4). Information is collected from multiple sources 
(e.g., hospital-discharge data, treatment records, pathology reports, 
and death certificates) and is linked for each individual over time 
(e.g., the immunization schedule for a particular child over time and 
across multiple health care providers). This linkage of individuals over 
time is unique to registries. Registries have been used to monitor a 
wide range o f health events and have identified opportunities for 
public health prevention and control activities.
Registries can be facility- or population-based, although population- 
based registries from which incidence rates can be calculated are 
generally more useful. However, even if  population at risk is not 
known, facility-based registries can be useful for a variety of activities 
including descriptive analyses and assessment of treatment effective­
ness. The main limitation o f registries is that high-quality data 
collection systems are expensive to set up and maintain and, thus, 
are generally not available in all geographic areas (11). Also, the 
complexity o f the data collection process makes rapid turnaround 
of data difficult.
Surveys o f Reproductive-Age Women and 
Household Surveys
Information that can be obtained from surveys includes disease 
status, behaviors associated with disease, risk factors, and health 
services data. Reproductive health surveys can be either one-time, 
cross-sectional surveys, or large-scale, periodic surveys. Population- 
based information for non-notifiable diseases is often obtained solely 
through the use of surveys of individuals, which can capture cases 
that are not seen at a health facility. One-time surveys do not provide 
information that can be used for assessing trends; ongoing or periodic 
surveys are more useful for surveillance purposes because rates can be 
monitored over time in a specific region.
Reproductive health surveys provide high-quality data and are 
routinely conducted by developed countries; however, the expense o f 
conducting such surveys is a serious limitation for developing countries.
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Community Identification
Community identification o f health events occurs when persons 
sometimes referred to as “key informants” report information from 
the community to the health sector (7). Key informants may be 
traditional birth attendants, village health workers, village leaders, 
or simply well-connected individuals in the community. For ex­
ample, maternal deaths that occur in a community may not be 
reported to a health facility and therefore would not be counted 
in a facility-based surveillance system. Maternal deaths occurring 
outside the health system must be identified and investigated be­
cause these women often die from different causes than do women 
who die in hospitals. The community identification approach is 
important for situations in which a significant proportion o f health 
events do not occur within the health care delivery system and, thus, 
are not identified through any o f the other surveillance methods 
discussed earlier.
In some settings, estimates o f reproductive health events cannot 
be obtained through direct methods o f measurement. The 
sisterhood method is an indirect method of community identification 
o f maternal deaths that makes use o f information on maternal 
deaths obtained by the addition of questions to demographic or 
community-based household surveys (14). This method, in which 
a representative sample o f adults is asked questions regarding the 
survivorship o f their sisters, provides basic information for the 
calculation of women’s lifetime chances of death from maternal 
causes. The sisterhood method requires smaller sample sizes than 
traditional methods and is relatively easy to use in the field.
One o f the main problems with the sisterhood method is that it 
yields no information on the causes or circumstances surrounding 
the maternal deaths. Furthermore, the method is highly dependent 
on the prevalence o f maternal mortality in the population. This 
method relies on the idea that siblings maintain contact throughout 
their lives. This assumption may not be true in settings where 
women leave the maternal home upon marriage and perhaps 
migrate to other parts o f the country. The sisterhood method 
tends to underreport early pregnancy deaths, especially those related 
to abortion or those that occur among unmarried women. Moreover, 
the sisterhood method can only give a retrospective estimate for the 
Maternal Mortality Ratio for the past 10 years (15). Nevertheless, 
the sisterhood method is useful for deriving population-based 
estimates o f maternal mortality in areas where the alternative data 
sources and approaches to estimation are inadequate, such as areas 
with poorly maintained or nonexistent vital registration systems.
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Typ es  o f  Su r v e il l a n c e  Sy s t e m s
Comprehensive Versus Sentinel Reporting
Comprehensive reporting systems collect information on all cases o f a 
particular health event under surveillance. Routinely collected data 
on patient care are aggregated on a regular basis and reported. Rou­
tine patient care data collection usually includes the whole spectrum 
of health events seen by the health facility and may include hospital 
records, home visits, and outreach efforts by health workers. Other 
sources of comprehensive data for a surveillance system are notifiable 
disease reports and reproductive health surveys. Since comprehensive 
reporting provides a wide range o f information to the collecting 
agency, careful scrutiny may be required to identify important trends 
and changes. Comprehensive reporting systems are commonly used 
in developing countries, where resources for data collection targeted 
toward particular health events may be extremely limited.
In contrast, sentinel surveillance monitors key health events through 
selected sites, geographic areas, events, providers, or vectors (16). In 
this system, selected health facilities are designated as sentinel sites and 
are required to report the health event under surveillance. Although 
sentinel sites may be obtained from a sample, usually they are chosen 
because of the likelihood of observing the particular health event at 
that site and for their cooperation in reporting. Sentinel surveillance 
encompasses a wide range of health activities for the purpose of 
obtaining timely information.
In a sentinel system, data typically are reported weekly so that out­
breaks and other unusual health events can be detected quickly. Since 
fewer sites are involved, data collected from sentinel sites are usually 
more accurate and complete, and data collection is less expensive than 
in comprehensive surveillance systems. The information obtained from 
sentinel systems, however, is usually not representative o f the general 
population and is often insufficient to calculate rates and ratios.
Population-Based Versus Facility-Based Systems
Population-based is a term used to describe information collected 
for all persons in a certain geographic unit, as opposed to facility- 
based information, which may represent only persons from the 
catchment area o f a given health facility. Population-based surveil­
lance is especially important in many developing countries because 
of disparities in access to health facilities and health status between 
urban and rural areas. Methods of population-based surveillance 
include vital registration, periodic reproductive health surveys, and
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surveillance at the local level (i.e., the lowest level o f the health 
system). Facility-based surveillance may include exit interviews, focus 
groups, and reviews o f health clinic records, and supervisory and 
evaluation reports. Focus groups are often used as a first step in 
generating ideas about why events and behaviors occur and are useful 
in the design o f surveillance systems (1). Exit interviews entail inter­
viewing patients who have finished their visits at health facilities. Exit 
interviews are ideal for measuring progress at the local level and can 
be used to collect information on process indicators of health objec­
tives, health risks, health behavior, and health interventions (17).
An important consideration in the design o f surveillance systems is 
that facility-based systems generally do not include cases outside the 
health care delivery system. For example, a considerable percentage o f 
women in Tanzania go through labor and delivery at home; therefore, 
a facility-based surveillance system o f emergency obstetric complica­
tions will represent only a certain segment o f the population and may 
not yield accurate information about labor and delivery complica­
tions that can be extrapolated to the population.
Primary Versus Secondary Data
Data that are collected for the purposes o f surveillance are called 
primary data, and data that are collected for other reasons (i.e., 
administrative and financial records) but used for surveillance 
purposes are called secondary data. Although most surveillance 
systems collect data expressly for the purpose o f supporting that 
specific surveillance effort, secondary data sets are increasingly being 
used in surveillance (2). Secondary data sets, which may include data 
from community records and administrative data, usually differ from 
primary data sources in a number of ways. Secondary data can be an 
efficient and cost-effective source of surveillance data. Secondary data 
generally are not available on a timely basis, however, and thus are 
usually more useful for long-term rather than short-term interven­
tions. Furthermore, all the desired health and sociodemographic 
information may not be included since the data were not primarily 
collected for the purposes of surveillance. For example, health main­
tenance organization data systems have primarily been used for cost 
accounting. Recently, these large data systems have been used to 
investigate the adverse reactions to vaccines and to study the cost- 
effectiveness of family planning services in preventing the high 
costs o f unintended pregnancy.
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Passive Versus Active Surveillance
Primary surveillance data collection systems are usually classified 
as passive or active (18). Passive, or provider-initiated, surveillance is a 
form o f data collection in which health care providers send reports 
to a health department based on a known set of rules and regulations. 
Most routine surveillance relies on passive reporting, in which health 
care providers report notifiable diseases on an individual case basis 
to the local level. Surveillance of infant deaths in the United States 
offers another example of a passive reporting system, in which death 
certificates are forwarded to the U.S. Centers for Disease Control and 
Prevention with designated International Classification o f Diseases 
(ICD) codes. Passive systems are often limited by their lack o f com­
plete and representative data. They may not be sensitive enough 
to detect outbreaks. The advantage of passive systems is that they 
require less personnel to maintain than do active systems, and thus 
are less expensive.
Given the shortcomings of passive surveillance systems, more active 
systems may be necessary for conditions o f particular public health 
importance. Active, or health department-initiated, surveillance 
involves regular outreach and routine solicitation of reports from 
potential reporters to enhance the reporting o f specific diseases or 
conditions. In settings o f limited resources, active surveillance is often 
used for short periods for very discrete purposes, such as the elimina­
tion o f a particular condition from a population. Active surveillance 
can be used to assess the representativeness of passive reports, enhance 
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Co m p o n e n t s  o f  t h e  Su r v e il l a n c e  Pr o c es s
The process o f surveillance consists o f five main components: setting 
goals and objectives, data collection, data analysis, interpretation 
of data, and communication and dissemination of surveillance 
information that is directly linked to public health action.
Setting Goals and Objectives: Surveillance 
Based on Health Objectives and Program 
indicators
Identifying measurable health objectives, assigning them priority, and 
linking the design of the surveillance system to those objectives will 
produce a closer connection between the process o f surveillance and 
public health action (17). It is useful to start with the end in mind 
and decide on what public health action you want to take; what 
decisions do you need to make about a particular health problem?
The resulting surveillance system is more relevant to the users o f the 
information, which enhances the usability and effectiveness o f the 
system. Because of the inherent relationship between surveillance 
and health programs, the surveillance process helps in designing 
and refining health intervention programs, resulting in an efficient 
use of resources.
Indicators are useful in measuring progress toward predefined health 
objectives, as well as evaluating the health objective itself. An indica­
tor is a measurement that, when compared with either a standard or 
desired level of achievement, provides information regarding a health 
outcome or management process. Indicators can serve as markers 
of progress toward improved reproductive health status. (See “Useful 
Indicators in Reproductive Health Epidemiology” to the right.) An 
indicator can either be a direct measure o f impact, or an indirect one, 
which measures progress toward specified program goals. Indicator 
data are collected periodically over time to track progress toward 
system objectives. Impact indicators provide information on the end 
result, but do not provide insight into how the outcome was 
achieved. For this reason, combining impact indicators with process 
(program activities) and outcome (results o f those activities) indicators 
provides the best information to evaluate a surveillance system.
The issue o f classification o f indicators is widely debated, and definitions 
vary among different organizations, but process, outcome, and impact 
indicators are the main focus o f this discussion. Process indicators are 
generally easier to measure than outcome or impact indicators.
Useful Indicators in 
Reproductive Health 
Epidemiology
/mpact Indicators:Reflect changes in the 
primary health event of 
interest (i.e., morbidity, 
mortality) and other 
health outcomes.
Outcome Indicators:
Reflect changes in 
knowledge, attitudes, 
behaviors, or the 
availability of necessary 
services that result from 
program activities.
Process Indicators:
Specify the actions 
needed for program 
implementation in order 
to achieve the intended 
outcomes.
A d ap ted  from : Reproductive  
health in refugee situations: 
an inter-agency field m anual. 
Geneva, Sw itzerland : United 
Nations High Commissioner 
fo r R efugees; 1999.
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However, process indicators are limited in that they do not measure 
the effectiveness o f the process, nor do they measure the event o f 
primary interest (15). Thus, process indicators may not necessarily 
correlate with outcome measures. Accordingly, although process 
indicators are useful in the short term, outcome and impact measures 
ultimately must be used to measure actual changes in health status.
For each predefined health objective, the indicator for evaluating that 
objective should also be defined, as in the following example:




Process indicator 100% of pregnant 
women will be 




Num ber of women delivering in the 
specified time period who had been 
tested for syphilis during the pregnancy
x 100
N um ber o f live births in the specified 
time period
O utcom e indicator Reduce the percentage 
of pregnant women 
who test positive for 
syphilis at delivery 




N um ber o f pregnant women screened 
for syphilis in the specified time period 
who tested positive for syphilis
x 100
Num ber of pregnant women who 
were tested for syphilis at delivery in 
the specified time period
Impact indicator Reduce the perinatal 
mortality rate from 
y% to (y — n)%
Perinatal mortality 
rate
Num ber of deaths in the perinatal 
period (22 weeks gestation through 
7 days o f life) during a specified 
time period
x 1,000
Total num ber o f births (live births 
plus fetal deaths) during the same 
time period
Adapted from: Reproductive health in refugee situations: an inter-agency field manual. Geneva, Switzerland: United 
Nations High Commission for Refugees; 1999.
The purpose of linking surveillance to health objectives is to reinforce 
the concept that surveillance is a system that uses information from 
multiple sources to impact health status, rather than simply the 
reporting o f disease. Furthermore, linking assists planners to think 
creatively in efforts to build a surveillance system to measure all 
priority health objectives.
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Data Collection
The sources of data for public health surveillance and methods of 
data collection have been described in previous sections. In general, 
there are certain points to bear in mind regarding data collection. 
First, sources o f data and methods o f collection should be pretested 
to ensure feasibility. The training of personnel involved in data 
collection is an important step in establishing a surveillance system. 
Data collection instruments should ascertain the minimum informa­
tion required for surveillance of the health event in order to enhance 
the quality of data and avoid an additional burden on the health 
system. Each element of data collected by surveillance should have 
a clearly demonstrated use (2).
Routine methods of collecting data in a system can be cross-checked 
periodically with other methods to enhance completeness o f data; 
for example, notifiable disease reports can be supplemented with 
information from surveys or sentinel reporting. The instruments 
used for data collection should have a standardized format to 
facilitate data analysis and comparison o f results from other surveil­
lance systems or surveys. Standardizing the format o f data collection 
systems allows for ease of data entry with minimal errors. Use of a 
standardized format is becoming more important with the shift 
to applications of information technology to public health issues. 
Depending on the resources of the particular region, this shift may 
be either currently relevant or may occur in the future as resources 
become available.
Analysis of Surveillance Data
The ability to effectively analyze, interpret, and present surveillance 
data is an important skill for the public health worker. Regular and 
systematic collection of surveillance information allows the descrip­
tion o f health events over time in the population under surveillance. 
In conducting an analysis, surveillance data are usually compared 
with an expected value, as well as with baseline information. Thor­
ough analysis includes determination of both actual numbers and 
rates. As with other descriptive epidemiologic data, surveillance 
data are usually analyzed in terms of time, place, and person (1).
Time. Description by time is an important means o f detecting 
trends in the health event under surveillance. The comparison 
of the number of case reports received during a particular interval 
(i.e., days, weeks, months) may help to identify sharp changes in 
case counts within the time interval. Comparing the number of 
cases for a current time period with the number reported during
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Public Health Informatics
Public health informatics is the application o f information science and technology 
to public health practice and research (19). This definition of public health informatics 
encompasses more than computerizing public health information. It is the capability of available 
technologies to manage information— whether those technologies include pencil and paper, 
handheld calculators, computers, multimedia applications, or a network of global telecommunications 
(20). The goal of public health informatics is to “speed and simplify the conversion of hypotheses 
about the distribution and determinants of diseases in populations into usable information, and help 
to disseminate new knowledge in ways that will support public health practice" (19).
Public health informatics can be applied to several components of surveillance (20).
Recording and reporting of cases. The completeness of case reporting depends largely 
on the amount of effort it takes for the health practitioner to record and report the health event 
of interest, and the subsequent steps needed to continue the reporting process at all levels of 
the surveillance system. Two key concepts in enhancing reporting are standardization and 
integration. By using standardized classification systems for reporting health-related data 
(e.g., International Classification of Diseases, tenth revision [ICD-10]), surveillance data can 
be efficiently reported at all levels of the surveillance system. Standardized, structured record 
formats and variable definitions for reporting health-related data allow for flexibility in local data 
collection systems (e.g., different software applications, additional variables of interest at the local 
level), while creating an aggregate, integrated national database of health events.
Data transmission. The technologies associated with public health informatics facilitate 
the transmission of raw surveillance data through electronic transfers, telecommunications, and 
computer connectivity. The use of the Internet is increasing at all levels of surveillance, beginning 
with individuals entering their own personal information into Internet-based data systems.
Analysis of data. The use of a computer for analysis of surveillance data is critical for any 
but the most simple systems, and new technologies are changing the way analysis is done.
A primary example is the use of geographic information systems (GIS) to map and analyze 
changes in the spatial distribution of health events.
Reporting and disseminating surveillance findings. New informatics technologies have 
greatly increased the accessibility of surveillance findings through electronic transfer of reports, 
Internet access, and multimedia presentations. Additionally, new methods of presenting data in 
charts, graphs, and maps can enhance the visual perception of burden of disease and changes 
in disease trends over time. These visual displays can be highly effective in presenting surveillance 
data to decision makers, who can then rapidly take public health action.
The key to developing an effective surveillance system is making the best use of the available 
technologies and looking to the future to integrate new technologies where they will be most helpful. 
In designing and implementing any surveillance system, public health workers must address the 
following questions (20):
1. Which specific component tasks of public health surveillance can informatics technology help 
to perform more quickly, easily, and accurately?
28
Module 1: Public Health Surveillance Applied to Reproductive Health
2. For each task, which informatic functions are appropriate, useful, and applicable?
3. Which capabilities of this technology have already been put into use or are under 
development?
4. What potential uses of informatic technology can we identify now?
In countries with limited resources, a well-planned and -managed paper record system 
may continue to be the most efficient reporting system available. However, “as surveillance 
information systems are implemented, every effort should be made to incorporate 
standardized processes for system connectivity and integration, protocols for data exchange 
and information access, core health data elements, and standard classification schemes" (21).
F urther reading and information
Friede A, Blum HL, McDonald M. Public health informatics: how information-age technology 
can strengthen public health. Annu Rev Public Health 1995;16:239-52.
Groseclose SL, Sullivan KM, Gibbs NP, Knowles CM. Management of the surveillance 
information system and quality control of data. In: Teutsch SM, Churchill RE, editors. Principles 
and practice of public health surveillance. 2nd ed. New York: Oxford University Press; 2000. 
p. 95-111.
Kilbourne EM. Informatics in public health surveillance: current issues and future perspectives. 
MMWR I992;4I:S9I-S99.
Yasnoff WA, O’Carroll PW, Koo D, Linkins RW, Kilbourne EM. Public health informatics: 
improving and transforming public health in the information age.J Public Health 
Management Practice 2000;6:67-75.
Division of Public Health Surveillance and Informatics, CDC: http://www.cdc.gov/epo/ 
dphsi/index.htm
Health Informatics Worldwide: http://www.imbi.uni-freiburg.de/medinf/mi_list.htm 
International Medical Informatics Association: http://www.imia.org/
the same interval in previous years may help determine seasonal 
patterns of the health event. Graphing the occurrence o f a health 
event over time is a way to identify long-term (secular) trends. It is 
useful to note significant events that may have influenced secular 
trends on graphs of surveillance data. These events may include 
implementation or cessation of intervention programs, changes in 
the case definition used for surveillance, changes in public awareness 
of a condition, or increased intensity of surveillance. In addition, the 
delay between the occurrence o f health outcome and reporting o f the 
problem should be considered when analyzing surveillance data by
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/  \Framework for 
Data Analysis
1. Identify appropriate 
and feasible rates or 
indicators prior to 
data collection.
2. Calculate rates, ratios, 
proportions.
3. Prepare tables, graphs, 
and charts.
4. Compare rates with 
expected values, 
reference rates, and 
baseline rates.
5. Use statistical 
probability methods 
to determine whether 
apparent differences 
in rates are significant.





7. Identify subgroups 
at highest risk.
8. Identify factors 
potentially responsible 
for morbidity and 
mortality.
\ _______________________ y
time. To minimize inaccuracies in the data, the interval between case 
identification and report must be identified and used consistently for 
reporting of all cases. Selecting the appropriate interval for analysis is 
dependent on the health condition under study and can range from 
time of exposure to expression o f symptoms, from symptoms to 
diagnosis, or from diagnosis to report o f case to public health authorities.
Place. Analysis by place can help identify where an increase in cases 
is occurring and may also reveal isolated outbreaks of a health event 
that were not detected in the analysis by time. For example, even if 
the overall numbers of a particular problem are decreasing, levels 
(including increases) of the number of cases may vary by geographic 
location. The identification of these focal areas allows prevention 
resources to be targeted effectively. The size of the unit for geographi­
cal analysis is determined by the type of health event under surveil­
lance. For example, for some rare conditions, large areas such as 
states or countries may be appropriate, whereas for events that 
occur frequently or for outbreak situations, smaller areas may be 
more appropriate. However, the use o f smaller geographic areas 
must be balanced with a need for enough data to provide stable 
estimates. Analysis by place can be carried out using maps or tables; 
the availability of computers and software for spatial mapping allows 
more sophisticated analysis of surveillance data by place.
Person. The analysis of surveillance data by person provides informa­
tion on the characteristics of those experiencing the health problem 
or those most likely to be exposed to the health event under surveil­
lance. The most frequently used demographic variables for analyses 
by person are age, gender, and race or ethnicity. Other variables such 
as marital status, occupation, levels o f income, and risk factors for 
certain health outcomes may be helpful, although most surveillance 
systems do not routinely collect such information. Surveillance 
systems have also been used to study behavioral characteristics 
o f populations.
Interactions between time, place, and person can obscure important 
patterns of disease in specific populations. Proceeding from crude 
rates to variable-specific rates during the analysis phase may clarify 
the effects of interactions between time, place, and person and reveal 
more meaningful trends in the surveillance data. For information on 
calculating reproductive health rates and ratios using surveillance 
data, refer to Appendix A.
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Interpretation o f Surveillance Data
Adapted from: Janes GR, Hutwagner LC, Cates W  Jr, Stroup DF, Williamson GD. 
Descriptive epidemiology: analyzing and interpreting surveillance data. In: Teutsch SM, 
Churchill RE, editors. Principles and practice of public health surveillance. 2nd ed. New 
York: Oxford University Press; 2000. p. 112-67.
Interpretation is the process o f transforming the data obtained from 
the surveillance system into information for action. Quality data play 
a crucial role in allowing health staff to modify and refine the way 
they are doing things in the field, and in focusing the attention o f 
policymakers on the health status o f a population. Data should not be 
interpreted in isolation, but rather with a background knowledge o f 
the etiology, epidemiology, and natural history o f the disease or health 
event. Interpretation o f surveillance data provides information that 
can be used in identifying epidemics, monitoring trends, evaluating 
public policy, and projecting future needs.
Identifying epidemics. Through systematic surveillance, increases 
of a health event to epidemic proportions can be identified in data 
analysis. Surveillance data often provide adequate information to 
detect increases in the prevalence o f a health event. In the interpreta­
tion phase, it is important to consider whether trends are stable, 
gradually rise and fall, or show occurrence o f an abrupt increase 
over that which was expected. Several factors, however, could result 
in an increase in the number o f cases reported, including population 
changes due to migration, improved diagnostic procedures, enhanced 
reporting techniques, and changes in the surveillance system or 
methods. Although any variation in the incidence or prevalence 
of a health event should be taken seriously, it is important to 
consider these factors when making any inferences.
Monitoring trends. Long-term temporal trends in surveillance data 
should be explained in the interpretation phase. Surveillance is 
especially critical in chronic diseases and reproductive health, in 
which interventions based on long-term trends have more impact 
than in epidemics, which require rapid investigation and control 
measures. Collection of regular, systematic surveillance data enables 
adequate monitoring of various health events and can help in deter­
mining appropriate intervention and prevention strategies.
Evaluatingpublic policy. Health interventions and the effect of 
policies on these interventions can be evaluated using surveillance 
data. Evaluating surveillance data can enhance management decision­
making for more efficient resource utilization, improved program 
operations, and maximum public benefit.
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Projecting future needs. Future trends can be predicted by looking at 
current surveillance data and applying mathematical models to these 
data. For example, when changes occur in risk factors among a popula­
tion at risk for a health event, changes in morbidity and mortality from 
that health event can be predicted using surveillance data.
Limitations of surveillance data. Several things should be kept in 
mind when analyzing data from surveillance systems. First, knowl­
edge o f the strengths and weaknesses o f  the data collection methods 
and reporting system will provide insight on the trends that emerge 
from the analysis o f data; that is, are the observed trends in data 
“real”? Analysis should proceed from the simplest procedures to the 
most complex. Be aware o f the quality of data collected and of any 
discrepancies if reporting from multiple sources, because these factors 
will, in turn, dictate the level of analysis that can be performed on the 
data with minimum bias and misinterpretation.
The accuracy of surveillance data is evaluated in terms of their 
reliability and validity. It is important to know whether the particular 
health event is reported consistently by different observers (reliabil­
ity), and also whether reports of the health event under study reflect 
the true condition as it occurs (validity). Another basic concept to 
consider in the analysis o f surveillance data is ecological fallacy. 
Ecological fallacy may occur when interpreting observations about 
groups. Ecological fallacy can be in the form of aggregation bias, 
which arises from loss of information when individuals are grouped, 
or specification bias, which arises from the definition o f the group 
itself. Care should be taken to reduce the chances of ecological fallacy 
by analyzing subsets of data to reveal disparate trends within the 
survey data.
Limitations o f the collected data must be recognized, interpreted, 
and reported. Underreporting may be inevitable because most 
surveillance systems are based on conditions reported by health 
care providers. However, so long as the underreporting is relatively 
consistent, incomplete data can still be used to identify disease trends. 
Another surveillance issue is that reporting biases can distort estimates 
of disease burden. For example, a health problem that leads to hospi­
talization may more likely be reported than problems seen on an 
outpatient basis. This bias may be reduced by adjusting for skewed 
reporting, or by collecting data from multiple sources where feasible. 
W hen interpreting surveillance data, one should be aware o f inconsis­
tencies in case definitions and any changes in existing definitions that 
may affect the accuracy o f case reports. Overall, data analysts need
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to ensure representativeness in the reported cases, consistency in case 
definitions, and a commitment to enhancing the timeliness in data 
collection and reporting.
Communication o f Findings From Surveillance
Communicating the results o f surveillance is the next step in the 
process o f transforming the data into information for action (22). 
Information generated from surveillance serves to inform and moti­
vate the recipients, so it is more appropriate to communicate, rather 
than simply disseminate, surveillance information. Dissemination 
implies a one-way process in which information is conveyed from 
one point to another, whereas communication is a collaborative 
process involving at least a sender and a recipient. Thus, the process 
of communicating surveillance data is not complete until recipients 
acknowledge receipt (dissemination) and comprehension of the 
information (feedback). Health personnel are more likely to continue 
the challenging job of collecting information if they know what is 
being used and acted on.
People who need to receive communication about surveillance infor­
mation include those who report cases and supply data (e.g., health 
care providers, laboratory directors), and those who need to know 
for administrative, program planning, and decision-making purposes 
(22). It is critical that the results and recommendations generated by 
the data lead to concrete action for achieving predetermined health 
objectives. Table 5 lists guidelines for communicating surveillance 
information:
Table 5. Framework for Dissem inating Results o f  Public H ealth Surveillance
Controlling and Directing Information Dissemination
Steps Q uestions to Be Answered
Establish communications message W hat should be said?
Define audience To whom should it be said?
Select the channel Through what communication medium?
M arket the message H ow  should the message be stated?
Evaluate the impact W hat effect did the message create?
Adapted from: Goodm an RA, Remington PL, Howard RJ. Com municating information for action w ithin the public
health system. In: Teutsch SM, Churchill RE, editors. Principles and practice of public health surveillance. 2nd ed.
New York: Oxford University Press; 2000.. p. 168-75.
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Depending on available resources and the needs o f the audience, 
many possible channels of communication exist for surveillance data, 
including simple chalkboards, posters and pamphlets, formal publica­
tions, electronic media (telecommunications systems, fax, and audio 
and videoconferences), mass media, and public forums. Irrespective 
of the target audience or channel of communication, the information 
should be presented in a clear and simple format. Graphic formats 
and other visual displays are likely to be more effective in conveying 
information than conventional tabular presentations of figures.
The communication aspect of surveillance should be periodically 
evaluated to ensure that the surveillance information is being 
communicated to those who need to know and that the information 
is benefitting the population through initiation of appropriate public 
health action or response. Although formal evaluations may not 
always be conducted, these objectives should always be considered 
when planning the communication of surveillance data. Ultimately, 
effective communication o f public health surveillance information 
represents the critical link in translating scientific information into 
public health practice.
Im plementing Public Health Action 
Based on Surveillance Data
The implementation of public health action as a result of information 
linked through surveillance depends primarily on how effectively 
the data are disseminated to public health officials and policymakers 
responsible for directing and funding public health strategies and 
programs. Analysis and interpretation of surveillance data provide 
a basis for the identification o f problems and possible solutions 
within the health care sector. Ongoing surveillance activities 
permit assessment and modification o f intervention efforts already 
in progress. W hen data are provided in a timely fashion to the health 
sector, they may be used for the planning, development, implementa­
tion, and evaluation o f public health programs. This connection 
between data collection and public health action continues to be 
the vital link that underscores the value and utility o f surveillance 
as a tool (2).
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Ev a l u a t io n  o f  Su r v e il l a n c e  Sy s t e m s
Regular review of an established surveillance system allows health 
staff to modify and refine health actions taking place in the field.
It can also be the first step in assessing how to address the need for 
surveillance information for a new health outcome— whether that 
information can be collected by modifying an existing system or 
whether a new system is needed. Evaluation o f surveillance systems 
is a key step in promoting the best use o f public health resources 
and should include recommendations for improving quality and 
efficiency. Evaluation of surveillance systems promotes the 
best use of public health resources by ensuring that public health 
problems are under surveillance, that surveillance systems operate 
efficiently, and that information disseminated by surveillance systems 
is useful for public health practice (23). Evaluation of a public health 
surveillance system involves an assessment o f the system’s attributes, 
including sensitivity, timeliness, representativeness, predictive value, 
accuracy and completeness of descriptive information, simplicity, 
flexibility, and acceptability (23). An evaluation of the system must 
consider those attributes that are of the highest priority for a particu­
lar system and its overall objectives.
Elements in Evaluation o f Surveillance Systems
A thorough evaluation should identify ways of improving the 
system’s operation and efficiency. CD C has an established system 
for evaluating surveillance systems (23), which is available at 
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm.
Briefly, in evaluating a surveillance system, the following tasks should 
be conducted:
A. Engage the stakeholder in the evaluation.
B. Describe the surveillance system to be evaluated.
1. Describe the public health importance of the health-related 
event under surveillance.
2. Describe the purpose and operation of the surveillance system.
3. Describe the resources used to operate the system.
C. Focus the evaluation design.
1. Determine the specific purpose o f the evaluation.
2. Identify stakeholders who will receive the findings and recom­
mendations of the evaluation.
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3. Consider what will be done with the information generated 
from the evaluation.
4. Specify the questions that will be answered by the evaluation.
5. Determine standards for assessing the performance o f the 
surveillance system.
D. Gather credible evidence regarding the performance o f the 
surveillance system.
1. Indicate the level of usefulness.
2. Describe each system attribute.
E. Justify and state conclusions, making recommendations.
F. Ensure use of evaluation findings and share lessons learned.
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Module 1: Public Health Surveillance Applied to Reproductive Health Case Studies
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Re p r o d u c t iv e  He a l t h  Su r v e il l a n c e  Sy s t e m  
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Learning Objectives
After completing this case study, the participant should be able to:
• Outline the elements o f evaluating a surveillance system.
• Discuss the factors contributing to the public health importance of 
a health event.
• Provide examples of impact, process, and outcome indicators useful 
in evaluating a reproductive health surveillance system.
• Assess the usefulness of the information being collected and of the 
information flow of the surveillance system as a whole.
• Evaluate the surveillance system in terms o f the following 
attributes: simplicity, flexibility, acceptability, sensitivity, predictive 
value positive, representativeness, and timeliness.
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Background
The reproductive health of women is especially vulnerable in a crisis 
situation such as exists at a refugee camp. In addition to the lack of 
normal sources of reproductive health care (e.g., family planning, 
prenatal care, safe delivery), the disruption of normal social patterns 
can lead to sexual violence, unplanned pregnancies, unsafe abortions, 
and increased incidence of sexually transmitted diseases. Even in the 
most organized refugee settings, the reproductive health needs of 
women often go unnoticed and unprotected.
In 1991, Azerbaijan declared its independence from the Soviet 
Union. In 1992, ethnic Armenians occupied the disputed region of 
Nagorno-Karabakh and surrounding regions in Azerbaijan. By 1996, 
there were 845,000 refugees or internally displaced persons (IDPs) in 
Azerbaijan. The deterioration o f the existing health system caused a 
shift from pregnant women delivering in government hospitals to 
delivering at home with local midwives instead o f government- 
employed physicians. During this time, there was no effective family 
planning program in Azerbaijan, mostly due to cultural attitudes, 
high costs of birth control, and limited availability of and access to 
up-to-date information.
In 1996, a relief organization established the Reproductive Health 
Surveillance System to help meet the reproductive health needs o f 
refugee and displaced women in Azerbaijan. By 1998, this organiza­
tion operated 6 reproductive health clinics and 11 mobile units 
serving 14 rural districts throughout central Azerbaijan. The follow­
ing services were offered to the women: a physical, gynecological, 
and pelvic examination; family planning counseling; STD and PID 
treatment; reproductive health education; and provision of contracep­
tive supplies. Abortions were not provided in the clinics; however, 
women who wished to obtain an abortion were referred to a govern­
ment hospital. Some of the early findings of the surveillance system 
showed that a high number o f abortions and frequent clinic visits for 
pelvic infections were occurring among these women. In 1998, an 
evaluation of this surveillance system was conducted.
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Evaluation o f Surveillance Systems
Regular review of an established surveillance system allows health staff 
to modify and refine health actions taking place in the field. Evalua­
tion o f surveillance systems is an important step in promoting the 
best use o f public health resources and should include recommenda­
tions for improving quality and efficiency. Most importantly, an 
evaluation should assess whether the system is serving a useful public 
health function and is meeting the system’s objectives.
Q1: Regular review of an established surveillance system is necessary 
to assess its usefulness, cost, and quality, and to direct possible 
modifications. List the steps to take in evaluating a surveillance 
system.
Family Planning, Abortion, and Public Health 
Burden o f PID in Azerbaijan
Abortion has long been the primary method o f birth control in 
Azerbaijan, as in much of the former Soviet Union. According to 
national statistics, the contraceptive prevalence rate (primarily for 
oral contraceptive pills and IUDs) was less than 1% before 1992, 
1.4% in 1996, and 2% in 1997. The rate of abortions in 1990 was 
14 per 100 deliveries. However, after Azerbaijan’s independence, the 
rate o f abortions rose to 23 per 100 deliveries in 1994. Alarmingly, 
data on complications associated with clinical abortions indicate a 
tremendous increase since the early 1990s.
Data from the Reproductive Health Surveillance System showed 
that refugee and IDP women visiting clinics were experiencing high 
rates of postabortion infections, many of which were reported to be 
pelvic inflammatory disease (PID). Anecdotally, many women were 
having abortions for “menstrual regulation” without first having a 
pregnancy test.
PID encompasses a spectrum of inflammatory disorders of the upper 
female genital tract. It is caused by bacteria, most often those respon­
sible for sexually transmitted diseases such as gonorrhea and chlamy­
dia; other pathogens, such as those that cause bacterial vaginosis, may 
also be responsible for the development o f PID. It is estimated that
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between 10% and 20% o f cervical gonococcal or chlamydial infec­
tions may progress to PID when left untreated (23).
Acute PID is difficult to diagnose because o f the wide variability in 
symptoms and severity among women. As a consequence, delay in 
diagnosis and effective therapy probably contribute to inflammatory 
sequelae in the upper reproductive tract. Long-term complications o f 
PID include ectopic pregnancy, infertility, pelvic adhesions, and 
chronic pelvic pain (24). Diagnosis is further complicated by the lack 
of a widely accepted clinical criteria for PID.
Q2: Health events that affect many people clearly have public health 
importance, as do events that cluster in time and place, affecting 
relatively few people. In a refugee setting, reproductive health 
may not be prioritized until the initial emergency phase is 
stabilized. However, once high mortality rates are under control 
and basic needs properly addressed, complete and integrated 
reproductive health services can be planned (25). W hat questions 
would be useful to ask in ascertaining the public health impor­
tance of surveillance for PID among refugee women in 
Azerbaijan?
Evaluation o f the Surveillance System for PID
The Reproductive Health Surveillance System had been in place for 
more than two years before the preliminary evaluation conducted in 
July 1998. Routine monthly data collected at the stationary clinics 
indicated that a large proportion of the women had symptoms 
associated with postabortion pelvic infection, which was considered 
to be PID. This review of the data helped to define a new program 
objective to decrease the incidence of symptomatic cases of PID by 
15%. In addition, the majority of these symptoms were associated 
with recent induced abortion. Strategies to reduce the number o f PID 
cases focused on ways to prevent PID associated with induced abor­
tion, including decreasing the number of women relying on abortion 
as their sole method of birth control and increasing access to family 
planning services.
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The evaluation of surveillance systems generally involves the defini­
tion o f indicators to track the progress toward explicit, quantifiable, 
and time-limited objectives (26). Once the objectives of a surveillance 
system have been defined, indicators are used as markers o f progress 
toward improved reproductive health. Indicators can either be direct 
measures o f  impact, or indirect measures o f progress toward specified 
process goals. An indicator can be thought of as a measurement that 
provides information regarding a health outcome, when compared 
with a standard or desired level o f achievement. Indicators are re­
peated over time to track progress toward the system objectives. 
Impact indicators provide information on the end result, but do not 
provide insight into how the outcome was achieved. For this reason, 
combining impact indicators with process (program activities) and 
outcome (results of those activities) indicators provides the best infor­
mation to evaluate a surveillance system.
Q3: W hat is the new program objective adopted after the 
preliminary evaluation in July 1998?
Q4: In terms o f the surveillance system for PID among Azeri refugee 
women, fill in the blank spaces below with examples o f each o f 
the three indicators that could be used to track progress toward 
achieving the objectives o f the system.
Useful Indicators for Evaluating a Reproductive Health Surveillance System
<u& Description Reproductive Health Example
Im pact Reflects changes in health status expected
to result from program activities
O utcom e Reflects changes in knowledge, attitudes,
behaviors, or the availability of necessary
services that result from program
activities
Process Specifies the actions needed for program
im plementation in order to achieve
the intended im pact and outcomes
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Once the indicators are in place, it may be necessary to restructure 
the surveillance system to collect information relevant to the 
indicator. An assessment of the monthly surveillance form in use 
before the evaluation revealed several missing links between program 
objectives and data being collected in the field. It was found that 
the information being collected was inadequate for determining 
the differences in incidence o f postabortion-complicated and 
nonprocedure-related cases of symptomatic PID. Data on the hospital 
performing the abortion were not being collected. There were no data 
collected on IUD insertion and incidence of PID. Also, self-reported 
PID was not being captured. However, after the addition of a few 
simple questions that served to distinguish between the causes 
of infection, health workers would be able to evaluate trends in 
PID visits, estimate the proportion of PID likely due to postabortion 
complications, and examine the impact of health education and 
interventions on PID prevention. In this way, the surveillance system 
became linked to the program objective o f reducing the incidence 
of symptomatic cases of PID by 15%.
Once the collection of relevant surveillance data has begun, simple 
calculations may be useful in monitoring monthly progress. Monthly 
reporting can be used as a way of showing what work is being done 
in the field, as well as producing a measurable improvement in the 
indicators. The following is an example o f a simple chart that could 
be included in monthly feedback reports:
Number o f  Postabortion-Com plicated Cases o f  PID , August—September 1998
August 1998 September 1998
Num ber o f postabortion infection cases seen
in clinics ..................................................................................................... ...................................... 195 188
Num ber o f women diagnosed with postabortion- 
complicated P ID  ...................................................................................... ...................................... 177 145
Percentage of postabortion-complicated P ID  cases
out of total num ber of postabortion infection cases........................ ...................................... 90% 77%
In August and September of 1998, a large proportion of women 
classified as “postabortion infectional” was diagnosed with 
postabortion-complicated PID, providing strong evidence for the 
relationship between abortion and PID. Perhaps the most effective 
way o f presenting this information is graphically, so that anyone can 
see at a glance the trend from month to month. W hen presented 
graphically, for instance, as a line graph o f  the percentage o f PID 
cases out o f total number o f postabortion infectional cases seen each
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month, the information could be used as a tool to focus the attention 
o f decision makers on PID as a public health problem, mobilize 
public health resources to address PID treatment and prevention, and 
guide and refine the relief program that is being put in place. In sum, 
“good” data are reliable, accurate, and presented in a way that anyone 
can understand (16).
Q5: Develop a shell o f a graph to monitor whether the new program 
objective is being met, based on the indicators. Label the axes, 
title, and key o f the graph.
Case D efinition o f PID
In this refugee setting, women attending any o f the six stationary 
reproductive health clinics present potentially important opportuni­
ties for the detection and management o f PID. Despite comprehen­
sive physical examinations, many episodes of PID go unrecognized. 
Although some cases are asymptomatic, others are undiagnosed 
because of mild or nonspecific symptoms. W ithout a clear case 
definition, it is also possible that some cases of “postabortion infec­
tion” may have been diagnosed as PID erroneously. The lack of 
sensitive, specific, rapid, and inexpensive diagnostic tests for PID is a 
significant obstacle for case ascertainment, particularly among asymp­
tomatic women.
The wide variability of PID symptoms necessitates an alternative 
strategy for clinical diagnosis. In detecting symptomatic cases o f PID, 
the use o f clinical algorithms based on risk assessment and symptoms 
is an alternative strategy in settings with limited access to diagnostic 
tests. This strategy, also known as the syndromic approach, requires 
experience and continued training o f clinicians and can significantly 
influence the yield o f case ascertainment. Using this approach, a 
case of PID is identified if all of the following minimum criteria are 
present: 1) lower abdominal tenderness and pain; 2) adnexal tender­
ness; and 3) cervical motion tenderness. Additional criteria used 
to support a diagnosis of PID are oral temperature over 101°F and 
abnormal cervical or vaginal discharge (27). This case definition was 
adopted by the clinics, and health care providers were quickly trained 
in the use of the syndromic approach.
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Q6: W hat is the case definition of PID for this surveillance system?
Assess the ability of the surveillance system to capture symptom­
atic cases o f PID.
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The target population for PID surveillance is women attending any 
one of six stationary reproductive health clinics in Azerbaijan. The 
doctor or midwife for every woman seen at the stationary clinics fills 
out the women’s health card and the Women’s Reproductive Health 
(WRH) register each day. The data from the cards are tallied and 
entered on daily reporting forms. Each week, the daily reporting 
forms are compiled and sent to Baku, the capital city.
Information generated from surveillance serves to inform and moti­
vate the recipients, thereby enhancing collaboration and improving 
the level of reporting to the system. The surveillance report should 
include summary information on the occurrence of the health event 
by person, place, and time. In the surveillance system for PID, a 
data specialist computerizes and compiles a morbidity and mortality 
monthly report using the daily reporting forms. This report is gener­
ated within one week o f the end o f each month and disseminated 
for trend analysis and program development. The quarterly report 
is compiled and written by the field coordinator, and reviewed by 
the medical coordinator and country director in Baku. In order 
to provide information for appropriate action by health workers 
and decision makers, the quarterly report is disseminated to the 
relief organizations headquarters in the United States, the donor 
(United Nations High Commission on Refugees), and the Ministry 
o f Health in Baku.
Q7: Is the Reproductive Health Surveillance System a population- 
based or facility-based system? W hat are the advantages and 
disadvantages of this type of system? How might the type 
o f system affect the reported prevalence o f PID in this 
population?
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Often it is useful to sketch a simple flowchart to better illustrate the 
steps involved in processing the data obtained through the surveil­
lance system. This chart can help to answer the following important 
questions:
• W hat information is being collected? Is it what programs need?
• W hat are the reporting sources? W ho is supposed to report? Who 
actually does report?
• How are the data handled? How are they routed, transferred, and 
stored? Are there unnecessary delays?
• How are the data analyzed? By whom? How often?
• How is the information disseminated? How often are reports 
distributed? To whom? Is the information getting to all those who 
need to know?
Q8: Draw a simple sketch of the existing flow of data, and suggest 
some changes that would enhance the ability o f those using the 
data to make decisions and take actions.
It is important to give feedback to the workers in the field who are 
the primary source o f information. Discussions with clinic health 
workers revealed that they found the data collection system acceptable 
and not too burdensome; however, they felt that they were not 
receiving any feedback. For this reason, it is suggested that a link 
between the office in Baku and the local clinic staff would strengthen 
the surveillance system. This linkage, indicated by the dotted line 
(page 57), should enhance the timeliness of the system by making 
data available to local clinic staff both for immediate control efforts 
and for long-term program planning. At all levels of the system, the 
analyzed data should be used to reassess system indicators and to 
confirm whether program objectives have been met.
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Action
The recommendations from the July 1998 evaluation of the 
Reproductive Health Surveillance System included the following:
• Change in objectives to focus on an important reproductive health 
problem in this population.
• Change in indicators to monitor progress toward this objective.
• Change in data forms to collect information to calculate the 
indicators.
• Change in case definition for PID and training in how to use this 
case definition.
Most o f these changes were instituted during the following month, 
and the statistics for August and September 1998 reflected these 
changes. The health care providers quickly adapted to the new forms 
and were enthusiastic about their training in the syndromic approach 
in order to use the new PID case definition. W ith appropriate train­
ing and information, clinic health staff were able to adjust to using 
the syndromic approach to PID case detection with little difficulty.
Below are some data from the August and September 1998 monthly 
reporting forms.
August 1998 September 1998
Num ber o f sexually active women seen in the clinics.................. ...........................  1,123 987
Postabortion infectional ...................................................................... ...............................  195 188
PID Postabortion.......................................................................... ...............................  177 145
N ot abortion-related .......................................................... .................................... 1 7
Num ber o f women using contracep tion ......................................... ...............................  512 460
Q9: W hat indicators can you calculate from the table above? What 
are the interpretations o f these indicators and the data from the 
table?
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In addition to the actions taken to modify the surveillance system and 
change clinical practice, the results from the Reproductive Health 
Surveillance System were used to develop a retrospective cohort study 
to test the hypothesis that women who undergo abortions are at 
increased risk o f PID. Preliminary results from this study show that 
although abortion itself is not associated with PID, the following risk 
factors are:
• Husband or partner with a sexually transmitted infection.
• No antibiotics during the last abortion.
• Abortion without confirming pregnancy with a pregnancy 
test first.
• Preexisting bacterial vaginosis infection (although chlamydia 
and gonorrhea infection were not associated with PID).
Because o f the low number of women using methods o f contracep­
tion in this population, the relief organization has worked with other 
relief agencies in Azerbaijan as well as the Ministry o f Health, to 
increase family planning services and supplies at the national level 
for refugees/IDPs as well as for the general population.
Cost
The yearly budget for the operation of the reproductive health pro­
gram was $140,000 in 1997. This amount covers both the clinical 
care and the surveillance components of the six reproductive health 
clinics, including salaries, clinic equipment, travel and transportation, 
printing, and publishing reports.
Attributes o f the PID Surveillance 
System in Azerbaijan
Several qualities or attributes affect the operation and usefulness o f a 
surveillance system. The simplicity of a surveillance system refers both 
to its structure and ease of operation. Ideally, a surveillance system 
should be as simple as possible, while still meeting its objectives. The 
flexibility of a system is defined as the ability of a system to adapt to 
changing needs or operating conditions with little additional time, 
personnel, or allocated funds. In general, simpler systems will be more 
flexible since fewer components will need to be modified when 
adapting the system. The flexibility of a system often is judged best 
retrospectively, after a change has been put in place and its impact on 
the system can be evaluated. The acceptability of a system reflects the 
willingness of individuals and organizations to participate in the 
surveillance system.
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The primary means of assessing the sensitivity of a surveillance system 
is to estimate the proportion of the total number of cases in the 
population being detected by the system, assuming that most re­
ported cases are correctly classified. The sensitivity of a surveillance 
system is affected by the likelihood that 1) persons with the health 
condition will seek medical care; 2) the disease will be diagnosed, 
reflecting the skill o f health care workers and the sensitivity of diag­
nostic tests; and 3) given the diagnosis, the case will be reported to 
the system. Increasing the sensitivity of a system may enhance the 
detection o f epidemics and the understanding o f the natural course 
of an adverse health event in a defined population. W ith respect to 
surveillance, predictive value positive (PVP) is defined as the propor­
tion o f persons identified as cases who actually have the health event 
under surveillance. The PVP is directly related to the sensitivity and 
specificity of the health event, as well as the prevalence of the condi­
tion in the population; the PVP increases with increasing specificity 
and prevalence. A representative surveillance system accurately charac­
terizes the epidemiologic characteristics o f a health event in a defined 
population and time frame. Timeliness refers to the availability o f data 
and information in time for appropriate action and reflects the speed 
or delay between steps in a surveillance system. Improving the timeli­
ness of a surveillance system allows control and prevention activities 
to be initiated earlier.
Q10: Discuss the surveillance system for PID with respect to the
following attributes: simplicity, flexibility, acceptability, sensitiv­
ity, predictive value positive, representativeness, and timeliness.
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Q11: Describe the usefulness of this surveillance system. W hat have 
the data from this surveillance system been used for and what 
impact has the system had on reproductive health care for 
refugees in Azerbaijan?
_________________________Reproductive Health Epidemiology Series
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Answers
Q1: Regular review of an established surveillance system is necessary 
to assess its usefulness, cost, and quality, and to direct possible 
modifications. List the steps to take in evaluating a surveillance 
system.
a) Describe the public health importance of the health event.
b) Describe the surveillance system to be evaluated.
• List the objectives of the system.
• Describe the health system under surveillance, including the 
case definition.
• Draw a flowchart or diagram of the system.
• Describe the components and operation of the system.
Include information on surveillance population, time frame 
of data collection, type o f information collected, transfer and 
analysis of data, and distribution of reports.
c) Assess the level of usefulness of the surveillance system by 
describing actions taken as a result o f the data generated by 
the system.
d) Evaluate the system in terms of the following attributes:
Simplicity -  the extent to which a surveillance system is 
uncomplicated in structure and easy to operate.
Flexibility -  the extent to which a surveillance system can 
adapt to changing information needs or operating conditions 
with little additional cost.
Acceptability -  the willingness of individuals and organizations 
to participate in the surveillance system.
Sensitivity -  an estimate o f the proportion of the total number 
of cases in the community being detected by the system.
Predictive Value Positive (PVP) -  the proportion of persons identi­
fied as cases who actually have the condition under surveillance.
Representativeness -  the extent to which the surveillance system 
accurately characterizes the epidemiologic characteristics o f a 
health event in a defined population.
Timeliness -  the speed or delay between steps in the surveil­
lance system.
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e) Compare the direct costs of operating the surveillance system 
with the benefits obtained.
f) List your recommendations, addressing whether the system is 
meeting its objectives.
Q2: Health events that affect many people clearly have public health 
importance, as do events that cluster in time and place, affecting 
relatively few people. In a refugee setting, reproductive health 
may not be prioritized until the initial emergency phase is 
stabilized. However, once high mortality rates are under control 
and basic needs properly addressed, complete and integrated 
reproductive health services can be planned (26). W hat questions 
would be useful to ask in ascertaining the public health impor­
tance of surveillance for PID among refugee women in 
Azerbaijan?
A2:
a) W hat are some measures o f burden o f disease, for example, 
total number of cases, incidence, prevalence o f PID among 
refugee/internally displaced women in Azerbaijan, number o f 
postabortion-complicated cases of PID, number o f symptom­
atic cases of PID associated with IUD insertion, number of 
referrals for abortions?
b) Is an identifiable subgroup of the population at greater risk 
for PID, for example, women with histories o f abortion, 
women referred to particular hospitals for abortions, women 
of certain age groups, women with histories of IUD insertion?
c) Are there efficacious treatments or preventive measures for 
PID? And, furthermore, what are the physical, social, and 
emotional sequelae o f undetected and/or untreated PID?
d) W hat are the direct and indirect costs associated with PID, 
for example, medical-care expenses and lost worktime?
Q3: W hat is the new program objective adopted after the preliminary 
evaluation in July 1998?
A3: Decrease the incidence of symptomatic cases o f PID by 15%.
Q4: In terms o f the surveillance system for PID among Azeri refugee 
women, fill in the blank spaces below with examples o f each o f 
the three indicators that could be used to track progress toward 
achieving the objectives o f the system.
A4: In keeping with the objective of decreasing the incidence of symp­
tomatic PID by 15%, an example of an impact indicator is the
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U sefu l In d ic a to rs  fo r  E v a lu a tin g  a  R e p ro d u c tiv e  H e a l th  S u rv e illa n c e  S ystem
<ui y Description Reproductive Health Example
Im pact Reflects changes in health status expected 
to result from program activities
Percentage of women with postabortion-complicated 
cases of PID
O utcom e Reflects changes in knowledge, attitudes, 
behaviors, or the availability o f necessary 
services that result from program 
activities
Percentage of women relying on abortion as their 
sole m ethod of b irth  control
Process Specifies the actions needed for program 
implementation in order to achieve 
the intended impact and outcomes
Percentage of clinic providers trained in family 
planning services
percentage of women with postabortion-complicated cases of PID 
seen at the clinics each month. Outcome indicators relate directly to 
the priority intervention, the target population, or those charged 
with caring for the target population. The percentage of women 
relying on abortion as their sole method of birth control is an 
example of an outcome indicator that you would expect to decrease 
with the intervention. Process indicators correspond to various 
activities necessary to achieve the intended outcomes and impact, 
for example, training, supply of drugs and equipment, and health 
education. In this refugee setting, the percentage of health workers 
trained in providing family planning services could be used as a 
process indicator.
Q5: Develop a shell o f a graph to monitor whether the new program 
objective is being met, based on the indicators. Label the axes, 
title, and key of the graph.
A5: This is one example of a shell of a graph to monitor the indicators.
C h a n g e  in  P e rcen tag e  o fW o m e n  R e ly in g  o n  A b o rtio n  
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Q6: W hat is the case definition of PID for this surveillance system? 
Assess the ability of the surveillance system to capture symp­
tomatic cases of PID.
A6: A case of PID is identified if all of the following minimum 
criteria are present: 1) lower abdominal tenderness and pain;
2) adnexal tenderness; and 3) cervical motion tenderness. 
Additional criteria used to support a diagnosis of PID are 
oral temperature over 101°F and abnormal cervical or vaginal 
discharge.
In the clinics, the sensitivity of the system in detecting 
true cases of PID among refugee women is judged to be poor, 
mainly due to imprecise syndrome diagnosis, the lack of a 
gold standard, and the variability in clinical presentation. It is 
thought that a meaningful proportion of true cases o f PID are 
not being captured by the system. As health workers become 
better trained in using the syndromic approach to PID detec­
tion, the proportion o f true cases to the total number o f cases 
classified as PID should increase.
Q7: Is the Reproductive Health Surveillance System a population- 
based or facility-based system? W hat are the advantages 
and disadvantages o f this type o f system? How might the 
type o f system affect the reported prevalence of PID in this 
population?
A7: The Reproductive Health System is a facility-based system. 
Advantages of this system include a relatively simple method 
o f data collection in a defined facility-based population, with 
clinical verification of diagnoses and follow-up. The main 
disadvantage is the lack of information about women with 
PID who do not come to the clinic. This situation may cause 
the prevalence o f PID to be severely underestimated especially 
because PID is often asymptomatic and women may not come 
to the clinic for treatment.
Q8: Draw a simple sketch of the existing flow of data, and suggest 
some changes that would enhance the ability of those using the 
data to make decisions and take actions.
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A8:
Q9: W hat indicators can you calculate from the table below? What 








of women in clinics with PID
of PID cases associated with abortion
of women using a family planning m ethod
177/1,123 = 15.8% 
177/178 = 99.4% 
512/1,123 = 45.6%
145/987 = 14.7% 
145/152 = 95.4% 
460/987 = 46.6%
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b) Interpretation:
The prevalence of PID among women seen at RI clinics is 
about 15% (magnitude of problem). In these 2 months, the 
vast majority of PID is occurring among women who have 
had recent abortions (group at high risk). About 40% -45%  
of women are using family planning; therefore, a large percent­
age o f women may be relying on abortion as their primary 
means of family planning.
Q10: Discuss the surveillance system for PID with respect to the
following attributes: simplicity, flexibility, acceptability, sensitiv­
ity, predictive value positive, representativeness, and timeliness.
A10: The surveillance system for PID is judged to be relatively
simple, due to minimal levels and complexity of reporting. The 
information being collected on PID is extremely simple, to the 
point that additional questions are needed in order to calculate 
the indicators to judge whether the system is meeting the 
program objectives.
The system has proven to be sufficiently flexible in accommo­
dating the changes in program priorities. In spite of changes 
made to the surveillance forms, data compilation and reporting 
are accomplished in a timely fashion. W ith appropriate training 
and information, clinic health staff were able to adjust to using 
the syndromic approach to PID case detection with little 
difficulty.
PID surveillance among refugee women is acceptable, since 
PID has been recognized as a major public health issue in this 
setting. An assessment of the daily forms and monthly surveil­
lance forms reveals that health workers are collecting complete 
information.
The sensitivity of the PID surveillance system would be assessed 
by estimating the proportion o f the total number of refugee 
women who truly have PID that were captured by the system. 
The sensitivity of the system is judged to be poor, mostly 
because of the variability in clinical presentation and resulting 
imprecise syndrome diagnosis, as well as the unavailability 
of gold standard diagnostic tests. Furthermore, doctors and 
midwives require information and training in order to properly 
apply the syndromic approach to PID detection.
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In this setting, the PVP is defined as the proportion of refugee 
women diagnosed as having PID who truly have the condition. 
As the PVP is closely related to the clarity and specificity of the 
case definition, the PVP in detecting true cases of PID is judged 
to be poor.
Any selection bias introduced into the surveillance system has 
the effect o f decreasing its representativeness; therefore, signifi­
cant subpopulations excluded by the system must be identified. 
The integration of data collection in the 11 mobile reproductive 
health units operating in 14 rural districts throughout the 
central region o f the country would add to the representative­
ness o f the data generated by the surveillance system.
Even after the modifications to the data collection forms, 
the first two monthly summary reports were finalized and 
disseminated to the key players in the health system at the 
regular schedule, within one week o f the end of the previous 
month. Hence this system would be judged to be timely, since 
the short interval between data collection and analysis allows 
for early detection o f trends in PID occurrence.
Q11: Describe the usefulness of this surveillance system. W hat have 
the data from this surveillance system been used for and what 
impact has the system had on reproductive health care for 
refugees in Azerbaijan?
A11:
a) Magnitude o f problem: the surveillance system has collected 
information to estimate the magnitude of PID and abortion- 
related PID in refugee/IDP women visiting the clinics.
b) Identification o f high-risk groups: because the vast majority 
of women with PID had recently had an abortion, it was 
hypothesized that abortions were a major cause of PID
in this population.
c) Generate hypotheses and stimulate research: based on the 
above hypothesis, a retrospective cohort study was undertaken 
to test the hypothesis that induced abortion was a risk factor 
for PID in this population.
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d) Prioritize public health services: because o f the high number of 
abortions, the high rate o f abortion-associated PID, and the 
low contraceptive prevalence in this population, the relief 
organization is working with other relief organizations and the 
Ministry o f Health to increase family planning services and 
supplies for all women in Azerbaijan.
______________________Reproductive Health Epidemiology Series
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Module 1: Public Health Surveillance Applied to Reproductive Health Case Studies
Ca s e  St u d y  II: An  Ev a l u a t io n  o f  t h e  
Pe r in a t a l  Su r v e il l a n c e  Sy s t e m  o f  t h e  
H o s t  Co u n t r y
Learning Objectives
After completing this case study, the participant should be able to:
• Describe a perinatal (or other) surveillance system, specific to 
the host country.
• Outline the elements o f evaluating a surveillance system.
• Discuss the factors contributing to the public health importance 
o f a health event.
• Provide examples of process and outcome indicators useful in 
evaluating a reproductive health surveillance system.
• Assess the usefulness of the information being collected and of 
the information flow of the surveillance system as a whole.
• Evaluate the surveillance system in terms o f the following 
attributes: simplicity, flexibility, acceptability, sensitivity, 
predictive value positive, representativeness, and timeliness.
• Make recommendations for modifying the current perinatal surveil­
lance system in the host country.
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Ca s e  St u d y  II: An  Ev a l u a t io n  o f  t h e  
Pe r in a t a l  Su r v e il l a n c e  Sy s t e m  o f  t h e  
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Note to Instructors
This case study is meant to familiarize students with current data 
collection systems in their country and to allow students to evaluate 
and adapt the current system to meet their goals and objectives for 
perinatal surveillance. Although this exercise focuses on perinatal 
outcomes, this process could be easily adapted to focus on another 
health outcome of interest to students. Questions in this case study 
may also need to be slightly modified, depending on the level of 
surveillance information currently available in the country. For example, 
in countries with no formal perinatal surveillance system in existence, 
students will focus more on developing a system to meet their needs. 
In countries with more established systems, students will focus more 
on evaluating the current system and making recommendations.
Materials needed: Before the case study, the instructor will need to 
gather the relevant vital statistics and other forms currently in use in 
the country, as well as a description of the vital statistics system. You 
may want to ask a few students to do this in advance.
Students should break into teams of four to five participants.
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An  Ev a l u a t io n  o f  t h e  Pe r in a t a l  Su r v e il l a n c e  
Sy s t e m  o f  t h e  H o s t  Co u n t r y
Background
You are a member of your country’s Task Force on Perinatal Surveil­
lance charged with evaluating current information systems regarding 
perinatal health and making recommendations for any changes to 
improve surveillance of perinatal health.
Q1: A successful task force for evaluating a surveillance system is 
made up o f stakeholders, who will be involved in planning, 
implementing, and using the findings of the surveillance system 
and its evaluation. Stakeholders may include members of the 
local, regional, and national levels o f the Ministry o f Health, 
other government and community leaders, public health practi­
tioners, health care providers, maternal and child health pro­
grammers, members o f the community, and professional and 
voluntary organizations. Decide who the stakeholders for a 
perinatal surveillance system in your country are, and decide who 
in your team will represent each stakeholder.
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Goals and Objectives o f the Perinatal 
Surveillance System
The first step in either developing or evaluating a surveillance system 
is to identify the goals and objectives o f the surveillance system.
These goals and objectives are generally closely tied to the program­
matic goals and objectives, which are monitored by the surveillance 
system. For example, a programmatic goal may be to reduce perinatal 
mortality due to obstructed labor, with the specific objective of 
increasing the proportion o f births by cesarean section. This example 
leads to a surveillance system goal of being able to monitor perinatal 
mortality, with three specific measurement objectives: 1) perinatal 
mortality, 2) cause o f perinatal mortality, and 3) mode of delivery.
Q2: W hat are your goals and objectives for your Perinatal Surveil­
lance System? How do these relate to programmatic goals and 
?
Once you have clearly defined goals and objectives, you are ready to 
identify the indicators you will need, and, therefore, the data elements 
necessary for your surveillance system.
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Q3: For five priority objectives, list the appropriate indicators, 
type o f indicator, definition, and specific data source, using 
the following table. You may not be able to list data sources 
for all of your indicators— this will allow you to see what data 
are currently available to you and what data you may need to 
collect.







C-section rate Process Num ber o f pregnant women with 
C-section in a specific time and 
geographic period
N um ber of deliveries in the same 
time period and geographic area
Form #1201 -  
Hospital delivery log
Vital statistics
After you have filled in the table, discuss the following questions:
a) W hat is your balance of process versus outcome indicators?
If you have more process indicators than outcome indicators, 
you may need to re-evaluate your priorities. Are these priority 
indicators really going to allow you to assess your overall goal?
b) Are there indicators for which you do not have a data source?
If so, discuss the trade-offs between creating a new data element 
for the surveillance system versus dropping the indicator.
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Describing and Evaluating the 
Perinatal Surveillance System
Now that you have established goals, objectives, and indicators, and 
the task force has a clear idea o f  what it wants to accomplish, it is 
time to describe the surveillance system that will help you meet 
your objectives. The next steps will largely depend on your country’s 
current surveillance system. If  you have a fairly well-developed 
perinatal surveillance system in place, you will want to focus on 
evaluating and modifying the current system to meet your needs.
I f  your country does not have a perinatal system in place, you will 
want to focus on developing that system, incorporating as many o f 
the current data collection systems as possible (e.g., vital statistics, 
health facility reporting).
Q4: Refer to Appendix C. Updated Guidelines for Evaluating Public 
Health Surveillance Systems (28).
a) Describe the public health importance of perinatal health issues 
in your country (i.e., why do you need a perinatal surveillance 
system).




• Communication and dissemination
• Action
c) Draw a flowchart o f the perinatal surveillance system.
d) Using the current data collection forms, are you able to collect the 
necessary data for the indicators? If not, is the indicator important 
enough to collect a new data element? If  so, how will that data 
element be collected?
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Q5: Evaluate the perinatal surveillance system, including its useful­
ness, attributes, and cost (refer to Appendix C. Updated Guide­
lines for Evaluating Public Health Surveillance Systems).
Q6: W hat are the recommendations the task force will make to the 
Ministry of Health for modifying the current surveillance system 
or designing a new one?
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Module 1: Public Health Surveillance Applied to Reproductive Health Appendices
Ap p e n d ix  A. Co m m o n l y  Us e d  Ra te s  in  
Re p r o d u c t iv e  H e a l t h  Ep id e m io l o g y
Several epidemiologic measures can be used in reproductive health 
surveillance as indicators of process and outcome. Please see indi­
vidual chapters for detailed descriptions o f  definitions, uses, and 
interpretations o f  topic-specific measures. The following is a list o f  
some o f the most commonly used measures:






Risk of death due 
to pregnancy
Im pact N um ber of maternal deaths 
occurring in a given time period




Risk of death due 
to pregnancy
Im pact N um ber of maternal deaths 
occurring in a given time period




Percentage of deaths 
due to pregnancy
Im pact N um ber of maternal deaths in a given time period
N um ber o f deaths to women o f reproductive 







due to specific 
cause
Im pact N um ber of maternal deaths 
due to a specific cause
Total num ber of maternal deaths 






Outcome N um ber of pregnant women who are 
attended at least once by trained personnel 
and who deliver in the specified time period





Outcome N um ber of children aged 12-23 m onths who 
were fully vaccinated before their first birthday
Num ber o f children aged 12-23 months
Perinatal 
mortality rate
Deaths during the 
perinatal period
Impact Num ber of deaths during the perinatal period 
(from 22 weeks gestation through 7 days of life), 
or other specified time period
Total num ber o f births (live births plus fetal 
deaths) during the same time period
x 1,000
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continued









Impact N um ber o f live-born infants who die within 
< 28 days in the specified time period
Num ber o f live births in the same time period
x 1,000
Low birth weight 
percentage
N um ber o f live-born 
infants weighing 
< 2,500 grams
Impact N um ber of live-born infants weighing 
< 2,500 grams in the specified time period
Total num ber of live births (birth weight 




Incidence o f STDs Impact Num ber of new cases o f STDs reported 







Prevalence of STDs 
among pregnant 
women
Impact N um ber of women who deliver in the specified 
time period that test positive for a particular STD
Num ber o f women who deliver in the same 
time period who were tested for that STD
Stillbirth rate N um ber of infants 
born dead
Impact N um ber o f infants > 21 weeks/500 grams 
born dead in the specified time period
Total num ber o f live births and stillbirths 
in the same time period





moving from one 
level o f care to another
Outcom e N um ber o f women with a potential or actual 
obstetric complication moved to another site
Total num ber o f women with obstetric 
complications in the same area and within 
the same time period
Cesarean 
section rate
Proportion of women 
who have a cesarean 
section in a specific 
geographic area in a 
given time period
Outcom e N um ber of live-born infants delivered by 
cesarean section in a specific time and 
geographic area
N um ber of live births in the same geographic 
area and time period
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Ap p e n d i x  B. Re p r o d u c t i v e  H e a l t h  
Re f e r e n c e  Ra t e s  a n d  Ra t i o s
Adapted from: Reproductive health in refugee settings: an inter-agency field manual. 
Geneva, Switzerland: United Nations High Commissioner for Refugees; 1999. p. 110.
The following figures have been collected from various sources and 
cover different time periods. They are intended to give estimates of 
what may be expected in some populations. These figures indicate a 
possible range and may assist with resource planning and targeting 
specific programs— they are not intended to be used as definitive 
baseline rates or as rates to be achieved.
A bortions 10% -15% of all pregnancies may spontaneously abort before 20 weeks gestation
90% of these will occur during the first 3 months
15% -20% of all spontaneous abortions that occur require medical interventions
H ypertensive D isorder 




of all pregnancies will develop H D P
of all primigravida pregnancies will develop H D P
Labor and  Delivery 
co m p lica tio n s
15%
3% -7%
of all pregnancies will require some type of intervention at delivery 
of all pregnancies will require a cesarean section
10% -15% of all women will have some degree o f cephalopelvic disproportion 
(higher in poorer socioeconomic populations)
10% of deliveries will involve a secondary postpartum  hemorrhage 
(within 24 hours o f delivery)
0.1% -1.0% of deliveries will involve a secondary postpartum  hemorrhage 
(occurring 24 hours or more after delivery)
0.1% -0.4% deliveries will result in uterine rupture
0.25% -2.4% of all deliveries will result in some type o f birth trauma to the baby
1.5% of all births will have a congenital malformation (does not include 
cardiac malformations diagnosed later in neonatal period)
31% of these malformations will result in death
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R efe ren ce  R a te s  a n d  R a tio s  fo r  R e p ro d u c tiv e  H e a lth  In d ic a to rs
Regional Indicators
Ind icator Sub-Saharan Southeast Industrialized
Africa Asia and pacific c o u n tr ie s
Safe M otherhood
Crude Birth Rate (per 1,000 popu la tion )............................. ..........44 26 13
Neonatal M ortality Rate (per 1,000 live b irth s).................. ..........53 36 5
Perinatal M ortality Rate (per 1,000 live births) .................. ..........83 51 8
M aternal M ortality Ratio (per 100,000 live births) ........... ....... 971 447 31
Infant M ortality Rate (per 1,000 live births) ....................... ..........97 50 14
Coverage o f Antenatal Care (% )............................................. ..........63 65 95
Low Birth W eight Percentage (per 100 live b ir th s) ............ .......... 16 15 6
Births attended by trained health personnel (%) ................ ..........42 53 99
Institutional Deliveries (% of live b irths).............................. ..........20 41 98
Unsafe Abortion (1,000 women 15—4 9 ) ............................... ..........26 15 1
Anemia in Pregnant W omen (% )............................................ .......... 52 57 18
Coverage o f Tetanus Vaccination (Pregnant Women) ....... 46 49 —
STDs, inc lud ing  HIV/AIDS
STD Incidence Rate (per 1,000 population) ....................... ....... 254 160 77
AIDS Cases (per 100,000) ........................................................ .........  94 80 27
Fam ily P lann ing
Contraceptive Prevalence R ate................................................. ......  15.9 53.2 70.5
Source: United Nations Development Programme. H um an Development Report. New York: United Nations; 1997. 
W orld Health Organization. World Health Report. Geneva, Switzerland: World Health Organization; 1996. 
(Adapted from: Reproductive health in refugee settings: an inter-agency field manual. Geneva, Switzerland: United 
Nations High Commissioner for Refugees; 1999. p. 111.)
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Updated Guidelines 
for Evaluating Public Health Surveillance Systems
Recommendations from the Guidelines Working Group
Summary
The purpose o f evaluating public health surveillance systems is to ensure that 
problems o f public health importance are being monitored efficiently and 
effectively. CDC's Guidelines for Evaluating Surveillance Systems are being 
updated to address the need for a) the integration o f surveillance and health 
information systems, b) the establishment o f data standards, c) the electronic 
exchange o f health data, and d) changes in the objectives o f public health 
surveillance to facilitate the response o f public health to emerging health threats 
(e.g., new diseases). This report provides updated guidelines for evaluating 
surveillance systems based on CDC's Framework for Program Evaluation in 
Public Health, research and discussion o f concerns related to public health 
surveillance systems, and comments received from the public health 
community. The guidelines in this report describe many tasks and related 
activities that can be applied to public health surveillance systems.
INTRODUCTION
In 1988, CDC published Guidelines for Evaluating Surveillance Systems (1 ) to pro­
mote the best use of public health resources through the development of efficient and 
effective public health surveillance systems. CDC's Guidelines for Evaluating Surveil­
lance Systems are being updated to address the need for a) the integration of surveil­
lance and health information systems, b) the establishment of data standards, c) the 
electronic exchange of health data, and d) changes in the objectives of public health 
surveillance to facilitate the response of public health to emerging health threats (e.g., 
new diseases). For example, CDC, with the collaboration of state and local health 
departments, is implementing the National Electronic Disease Surveillance System 
(NEDSS) to better manage and enhance the large number of current surveillance sys­
tems and allow the public health community to respond more quickly to public health 
threats (e.g., outbreaks of emerging infectious diseases and bioterrorism) (2 ). When 
NEDSS is completed, it will electronically integrate and link together several types of 
surveillance systems with the use of standard data formats; a communications infra­
structure built on principles of public health informatics; and agreements on data 
access, sharing, and confidentiality. In addition, the Health Insurance Portability and 
Accountability Act of 1996 (HIPAA) mandates that the United States adopt national 
uniform standards for electronic transactions related to health insurance enrollment 
and eligibility, health-care encounters, and health insurance claims; for identifiers for 
health-care providers, payers and individuals, as well as code sets and classification 
systems used in these transactions; and for security of these transactions (3 ). The elec­
tronic exchange of health data inherently involves the protection of patient privacy.
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Based on CDC's Framework for Program Evaluation in Public Health (4 ), research 
and discussion of concerns related to public health surveillance systems, and com­
ments received from the public health community, this report provides updated guide­
lines for evaluating public health surveillance systems.
BACKGROUND
Public health surveillance is the ongoing, systematic collection, analysis, interpreta­
tion, and dissemination of data regarding a health-related event for use in public health 
action to reduce morbidity and mortality and to improve health (5-7 ). Data dissemi­
nated by a public health surveillance system can be used for immediate public health 
action, program planning and evaluation, and formulating research hypotheses. For 
example, data from a public health surveillance system can be used to
• guide immediate action for cases of public health importance;
• measure the burden of a disease (or other health-related event), including 
changes in related factors, the identification of populations at high risk, and the 
identification of new or emerging health concerns;
• monitor trends in the burden of a disease (or other health-related event), including 
the detection of epidemics (outbreaks) and pandemics;
• guide the planning, implementation, and evaluation of programs to prevent and 
control disease, injury, or adverse exposure;
• evaluate public policy;
• detect changes in health practices and the effects of these changes;
• prioritize the allocation of health resources;
• describe the clinical course of disease; and
• provide a basis for epidemiologic research.
Public health surveillance activities are generally authorized by legislators and car­
ried out by public health officials. Public health surveillance systems have been devel­
oped to address a range of public health needs. In addition, public health information 
systems have been defined to include a variety of data sources essential to public health 
action and are often used for surveillance (8 ). These systems vary from a simple sys­
tem collecting data from a single source, to electronic systems that receive data from 
many sources in multiple formats, to complex surveys. The number and variety of 
systems will likely increase with advances in electronic data interchange and integra­
tion of data, which will also heighten the importance of patient privacy, data confiden­
tiality, and system security. Appropriate institutions/agencies/scientific officials should 
be consulted with any projects regarding pubic health surveillance.
Variety might also increase with the range of health-related events under surveil­
lance. In these guidelines, the term "health-related event" refers to any subject related 
to a public health surveillance system. For example, a health-related event could 
include infectious, chronic, or zoonotic diseases; injuries; exposures to toxic substances; 
health promoting or damaging behaviors; and other surveilled events associated with 
public health action.
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The purpose of evaluating public health surveillance systems is to ensure that prob­
lems of public health importance are being monitored efficiently and effectively. Public 
health surveillance systems should be evaluated periodically, and the evaluation should 
include recommendations for improving quality, efficiency, and usefulness. The goal of 
these guidelines is to organize the evaluation of a public health surveillance system. 
Broad topics are outlined into which program-specific qualities can be integrated. Evalu­
ation of a public health surveillance system focuses on how well the system operates to 
meet its purpose and objectives.
The evaluation of public health surveillance systems should involve an assessment 
of system attributes, including simplicity, flexibility, data quality, acceptability, sensitiv­
ity, predictive value positive, representativeness, timeliness, and stability. With the con­
tinuing advancement of technology and the importance of information architecture 
and related concerns, inherent in these attributes are certain public health informatics 
concerns for public health surveillance systems. These concerns include comparable 
hardware and software, standard user interface, standard data format and coding, 
appropriate quality checks, and adherence to confidentiality and security standards 
(9 ). Because public health surveillance systems vary in methods, scope, purpose, and 
objectives, attributes that are important to one system might be less important to 
another. A public health surveillance system should emphasize those attributes that 
are most important for the objectives of the system. Efforts to improve certain attributes 
(e.g., the ability of a public health surveillance system to detect a health-related event 
[sensitivity]) might detract from other attributes (e.g., simplicity or timeliness). An evalu­
ation of the public health surveillance system must therefore consider those attributes 
that are of the highest priority for a given system and its objectives. Considering the 
attributes that are of the highest priority, the guidelines in this report describe many 
tasks and related activities that can be applied in the evaluation of public health surveil­
lance systems, with the understanding that all activities under the tasks might not be 
appropriate for all systems.
Organization of This Report
This report begins with descriptions of each of the tasks involved in evaluating a 
public health surveillance system. These tasks are adapted from the steps in program 
evaluation in the Framework for Program Evaluation in Public Health (4 ) as well as 
from the elements in the original guidelines for evaluating surveillance systems (1 ). 
The report concludes with a summary statement regarding evaluating surveillance sys­
tems. A checklist that can be detached or photocopied and used when the evaluation is 
implemented is also included (Appendix A).
To assess the quality of the evaluation activities, relevant standards are provided for 
each of the tasks for evaluating a public health surveillance system (Appendix B). These 
standards are adapted from the standards for effective evaluation (i.e., utility, feasibil­
ity, propriety, and accuracy) in the Framework for Program Evaluation in Public Health 
(4 ). Because all activities under the evaluation tasks might not be appropriate for all 
systems, only those standards that are appropriate to an evaluation should be used.
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Task A. Engage the Stakeholders in the Evaluation
Stakeholders can provide input to ensure that the evaluation of a public health 
surveillance system addresses appropriate questions and assesses pertinent attributes 
and that its findings will be acceptable and useful. In that context, we define stakehold­
ers as those persons or organizations who use data for the promotion of healthy 
lifestyles and the prevention and control of disease, injury, or adverse exposure. Those 
stakeholders who might be interested in defining questions to be addressed by the 
surveillance system evaluation and subsequently using the findings from it are public 
health practitioners; health-care providers; data providers and users; representatives 
of affected communities; governments at the local, state, and federal levels; and pro­
fessional and private nonprofit organizations.
Task B. Describe the Surveillance System to be Evaluated
Activities
• Describe the public health importance of the health-related event under 
surveillance.
• Describe the purpose and operation of the system.
• Describe the resources used to operate the system.
Discussion
To construct a balanced and reliable description of the system, multiple sources of 
information might be needed. The description of the system can be improved by con­
sulting with a variety of persons involved with the system and by checking reported 
descriptions of the system against direct observation.
B. 1. Describe the Public Health Importance of the Health-Related Event 
Under Surveillance
Definition. The public health importance of a health-related event and the need to 
have that event under surveillance can be described in several ways. Health-related 
events that affect many persons or that require large expenditures of resources are of 
public health importance. However, health-related events that affect few persons might 
also be important, especially if the events cluster in time and place (e.g., a limited out­
break of a severe disease). In other instances, public concerns might focus attention on 
a particular health-related event, creating or heightening the importance of an evalua­
tion. Diseases that are now rare because of successful control measures might be per­
ceived as unimportant, but their level of importance should be assessed as a possible 
sentinel health-related event or for their potential to reemerge. Finally, the public health 
importance of a health-related event is influenced by its level of preventability (10 ).
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Measures. Parameters for measuring the importance of a health-related event—  
and therefore the public health surveillance system with which it is monitored— can 
include (7 )
• indices of frequency (e.g., the total number of cases and/or deaths; incidence 
rates, prevalence, and/or mortality rates); and summary measures of population 
health status (e.g., quality-adjusted life years [QALYS]);
• indices of severity (e.g., bed-disability days, case-fatality ratio, and hospitalization 
rates and/or disability rates);
• disparities or inequities associated with the health-related event;
• costs associated with the health-related event;
• preventability (10 );
• potential clinical course in the absence of an intervention (e.g., vaccinations) 
(11,12 ); and
• public interest.
Efforts have been made to provide summary measures of population health status 
that can be used to make comparative assessments of the health needs of populations 
(13 ). Perhaps the best known of these measures are QALYs, years of healthy life (YHLs), 
and disability-adjusted life years (DALYs). Based on attributes that represent health 
status and life expectancy, QALYs, YHLs, and DALYs provide one-dimensional mea­
sures of overall health. In addition, attempts have been made to quantify the public 
health importance of various diseases and other health-related events. In a study that 
describes such an approach, a score was used that takes into account age-specific 
morbidity and mortality rates as well as health-care costs (14 ). Another study used a 
model that ranks public health concerns according to size, urgency, severity of the prob­
lem, economic loss, effect on others, effectiveness, propriety, economics, acceptability, 
legality of solutions, and availability of resources (15 ).
Preventability can be defined at several levels, including primary prevention (pre­
venting the occurrence of disease or other health-related event), secondary prevention 
(early detection and intervention with the aim of reversing, halting, or at least retarding 
the progress of a condition), and tertiary prevention (minimizing the effects of disease 
and disability among persons already ill). For infectious diseases, preventability can 
also be described as reducing the secondary attack rate or the number of cases trans­
mitted to contacts of the primary case. From the perspective of surveillance, prevent­
ability reflects the potential for effective public health intervention at any of these levels.
B.2. Describe the Purpose and Operation of the Surveillance System
Methods. Methods for describing the operation of the public health surveillance 
system include
• List the purpose and objectives of the system.
• Describe the planned uses of the data from the system.
• Describe the health-related event under surveillance, including the case definition 
for each specific condition.
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• Cite any legal authority for the data collection.
• Describe where in the organization(s) the system resides, including the context
(e.g., the political, administrative, geographic, or social climate) in which the
system evaluation w ill be done.
• Describe the level of integration with other systems, if appropriate.
• Draw a flow  chart of the system.
• Describe the components of the system. For example
—  What is the population under surveillance?
—  What is the period of time of the data collection?
—  What data are collected and how are they collected?
—  What are the reporting sources of data for the system?
—  How are the system's data managed (e.g., the transfer, entry, editing, storage, 
and back up of data)? Does the system comply with applicable standards for 
data formats and coding schemes? If not, why?
—  How are the system's data analyzed and disseminated?
—  What policies and procedures are in place to ensure patient privacy, data 
confidentiality, and system security? What is the policy and procedure for 
releasing data? Do these procedures comply with applicable federal and state 
statutes and regulations? If not, why?
—  Does the system comply with an applicable records management program? 
For example, are the system's records properly archived and/or disposed of?
Discussion. The purpose of the system indicates why the system exists, whereas its 
objectives relate to how the data are used for public health action. The objectives of a 
public health surveillance system, for example, might address immediate public health 
action, program planning and evaluation, and formation of research hypotheses (see 
Background). The purpose and objectives of the system, including the planned uses of 
its data, establish a frame of reference for evaluating specific components.
A public health surveillance system is dependent on a clear case definition for the 
health-related event under surveillance (7 ). The case definition of a health-related event 
can include clinical manifestations (i.e., symptoms), laboratory results, epidemiologic 
information (e.g., person, place, and time), and/or specified behaviors, as well as levels 
of certainty (e.g., confirmed/definite, probable/presumptive, or possible/suspected). The 
use of a standard case definition increases the specificity of reporting and improves the 
comparability of the health-related event reported from different sources of data, 
including geographic areas. Case definitions might exist for a variety of health-related 
events under surveillance, including diseases, injuries, adverse exposures, and risk fac­
tor or protective behaviors. For example, in the United States, CDC and the Council of 
State and Territorial Epidemiologists (CSTE) have agreed on standard case definitions 
for selected infectious diseases (16 ). In addition, cS te  publishes Position Papers that 
discuss and define a variety of health-related events (17 ). When possible, a public health 
surveillance system should use an established case definition, and if it does not, an 
explanation should be provided.
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The evaluation should assess how well the public health surveillance system is inte­
grated with other surveillance and health information systems (e.g., data exchange 
and sharing in multiple formats, and transformation of data). Streamlining related sys­
tems into an integrated public health surveillance network enables individual systems 
to meet specific data collection needs while avoiding the duplication of effort and lack 
of standardization that can arise from independent systems (18 ). An integrated system 
can address comorbidity concerns (e.g., persons infected with human immunodefi­
ciency virus and Mycobacterium tuberculosis ) ; identify previously unrecognized risk 
factors; and provide the means for monitoring additional outcomes from a health- 
related event. When CDC's NEDSS is completed, it will electronically integrate and link 
together several types of surveillance activities and facilitate more accurate and timely 
reporting of disease information to CDC and state and local health departments (2 ).
CSTE has organized professional discussion among practicing public health epide­
miologists at state and federal public health agencies. CSTE has also proposed a 
national public health surveillance system to serve as a basis for local and state public 
health agencies to a) prioritize surveillance and health information activities and 
b) advocate for necessary resources for public health agencies at all levels (19 ). This 
national public health system would be a conceptual framework and virtual surveil­
lance system that incorporates both existing and new surveillance systems for health- 
related events and their determinants.
Listing the discrete steps that are taken in processing the health-event reports by 
the system and then depicting these steps in a flow  chart is often useful. An example of 
a simplified flow chart for a generic public health surveillance system is included in this 
report (Figure 1). The mandates and business processes of the lead agency that oper­
ates the system and the participation of other agencies could be included in this chart. 
The architecture and data flow of the system can also be depicted in the chart (20,21 ). 
A chart of architecture and data flow should be sufficiently detailed to explain all of the 
functions of the system, including average times between steps and data transfers.
The description of the components of the public health surveillance system could 
include discussions related to public health informatics concerns, including compa­
rable hardware and software, standard user interface, standard data format and cod­
ing, appropriate quality checks, and adherence to confidentiality and security standards 
(9 ). For example, comparable hardware and software, standard user interface, and 
standard data format and coding facilitate efficient data exchange, and a set of com­
mon data elements are important for effectively matching data within the system or to 
other systems.
To document the information needs of public health, CDC, in collaboration with 
state and local health departments, is developing the Public Health Conceptual Data 
Model to a) establish data standards for public health, including data definitions, com­
ponent structures (e.g., for complex data types), code values, and data use; b) collabo­
rate with national health informatics standard-setting bodies to define standards for 
the exchange of information among public health agencies and health-care providers; 
and c) construct computerized information systems that conform to established data 
and data interchange standards for use in the management of data relevant to public 
health (22 ). In addition, the description of the system's data management might ad­
dress who is editing the data, how and at what levels the data are edited, and what 
checks are in place to ensure data quality.
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In response to HIPAA mandates, various standard development organizations and 
terminology and coding groups are working collaboratively to harmonize their sepa­
rate systems (23 ). For example, both the Accredited Standards Committee X12 (24 ), 
which has dealt principally with standards for health insurance transactions, and Health 
Level Seven (HL7) (25 ), which has dealt with standards for clinical messaging and 
exchange of clinical information with health-care organizations (e.g., hospitals), have 
collaborated on a standardized approach for providing supplementary information to 
support health-care claims (26 ). In the area of classification and coding of diseases and 
other medical terms, the National Library of Medicine has traditionally provided the 
Unified Medical Language System, a metathesaurus for clinical coding systems that 
allows terms in one coding system to be mapped to another (27 ). The passage of
FIGURE 1. Simplified flow  chart for a generic surveillance system
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HIPAA and the anticipated adoption of standards for electronic medical records have 
increased efforts directed toward the integration of clinical terminologies (23 ) (e.g., the 
merge of the College of American Pathologists' Systematized Nomenclature of Medi­
cine [SNOMED®] [28 ] and the British Read Codes, the National Health Service thesau­
rus of health-care terms in Great Britain).
The data analysis description might indicate who analyzes the data, how they are 
analyzed, and how often. This description could also address how the system ensures 
that appropriate scientific methods are used to analyze the data.
The public health surveillance system should operate in a manner that allows effec­
tive dissemination of health data so that decision makers at all levels can readily under­
stand the implications of the information (7 ). Options for disseminating data and/or 
information from the system include electronic data interchange; public-use data files; 
the Internet; press releases; newsletters; bulletins; annual and other types of reports; 
publication in scientific, peer-reviewed journals; and poster and oral presentations, 
including those at individual, community, and professional meetings. The audiences 
for health data and information can include public health practitioners, health-care pro­
viders, members of affected communities, professional and voluntary organizations, 
policymakers, the press, and the general public.
In conducting surveillance, public health agencies are authorized to collect personal 
health data about persons and thus have an obligation to protect against inappropriate 
use or release of that data. The protection of patient privacy (recognition of a person's 
right not to share information about him or herself), data confidentiality (assurance of 
authorized data sharing), and system security (assurance of authorized system access) 
is essential to maintaining the credibility of any surveillance system. This protection 
must ensure that data in a surveillance system regarding a person's health status are 
shared only with authorized persons. Physical, administrative, operational, and com­
puter safeguards for securing the system and protecting its data must allow authorized 
access while denying access by unauthorized users.
A related concern in protecting health data is data release, including procedures for 
releasing record-level data; aggregate tabular data; and data in computer-based, inter­
active query systems. Even though personal identifiers are removed before data are 
released, the removal of these identifiers might not be a sufficient safeguard for shar­
ing health data. For example, the inclusion of demographic information in a line-listed 
data file for a small number of cases could lead to indirect identification of a person 
even though personal identifiers were not provided. In the United States, CDC and 
CSTE have negotiated a policy for the release of data from the National Notifiable 
Disease Surveillance System (29 ) to facilitate its use for public health while preserving 
the confidentiality of the data (30 ). The policy is being evaluated for revision by CDC 
and CSTE.
Standards for the privacy of individually identifiable health data have been pro­
posed in response to HIPAA (3 ). A model state law has been composed to address 
privacy, confidentiality, and security concerns arising from the acquisition, use, disclo­
sure, and storage of health information by public health agencies at the state and local 
levels (31 ). In addition, the Federal Committee on Statistical Methodology's series of 
Statistical Policy Working Papers includes reviews of statistical methods used by 
federal agencies and their contractors that release statistical tables or microdata files
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that are collected from persons, businesses, or other units under a pledge of confiden­
tiality. These working papers contain basic statistical methods to limit disclosure (e.g., 
rules for data suppression to protect privacy and to minimize mistaken inferences from 
small numbers) and provide recommendations for improving disclosure limitation 
practices (32 ).
A public health surveillance system might be legally required to participate in a 
records management program. Records can consist of a variety of materials (e.g., com­
pleted forms, electronic files, documents, and reports) that are connected with operat­
ing the surveillance system. The proper management of these records prevents a "loss 
of memory" or "cluttered memory" for the agency that operates the system, and 
enhances the system's ability to meet its objectives.
B.3. Describe the Resources Used to Operate the Surveillance System
Definition. In this report, the methods for assessing resources cover only those 
resources directly required to operate a public health surveillance system. These 
resources are sometimes referred to as "direct costs" and include the personnel and 
financial resources expended in operating the system.
Methods. In describing these resources consider the following:
• Funding source(s): Specify the source of funding for the surveillance system. In the 
United States, public health surveillance often results from a collaboration among 
federal, state, and local governments.
• Personnel requirements: Estimate the time it takes to operate the system, including 
the collection, editing, analysis, and dissemination of data (e.g., person-time 
expended per year of operation). These measures can be converted to dollar 
estimates by multiplying the person-time by appropriate salary and benefit costs.
• Other resources: Determine the cost of other resources, including travel, training, 
supplies, computer and other equipment, and related services (e.g., mail, telephone, 
computer support, Internet connections, laboratory support, and hardware and 
software maintenance).
When appropriate, the description of the system's resources should consider all 
levels of the public health system, from the local health-care provider to municipal, 
county, state, and federal health agencies. Resource estimation for public health sur­
veillance systems have been implemented in Vermont (Table 1) and Kentucky (Table 2).
Resource Estimation in Vermont. Two methods of collecting public health surveil­
lance data in Vermont were compared (33 ). The passive system was already in place 
and consisted of unsolicited reports of notifiable diseases to the district offices or state 
health department. The active system was implemented in a probability sample of 
physician practices. Each week, a health department employee called these practitio­
ners to solicit reports of selected notifiable diseases.
In comparing the two systems, an attempt was made to estimate their costs. The 
estimates of direct expenses were computed for the public health surveillance systems 
(Table 1).
Resource Estimation in Kentucky. Another example of resource estimation was pro­
vided by an assessment of the costs of a public health surveillance system involving 
the active solicitation of case reports of type A hepatitis in Kentucky (Table 2) (34 ). The 
resources that were invested into the direct operation of the system in 1983 were for
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TABLE 1. Comparison of estimated expenses for health department active and passive 









Public health nurse 14,025 0
Total $19,271 $2,303
*V og t RL, LaRue D, Klaucke DN, J illson  DA. Com parison o f an active and passive surveillance 
system o f p rim ary  care providers fo r  hepatitis, measles, rubella, and sa lm onellosis in Verm ont. 
Am  J Public Health 1983;73:795-7.
+ Active  surveillance —  w eekly calls were made fro m  health departm ents requesting reports.
§ Passive surveillance —  provider-in itia ted  reporting.
personnel and telephone expenses and were estimated at $3,764 and $535, respec­
tively. Nine more cases were found through this system than would have been found 
through the passive surveillance system, and an estimated seven hepatitis cases were 
prevented through administering prophylaxis to the contacts of the nine case-patients.
Discussion. This approach to assessing resources includes only those personnel 
and material resources required for the operation of surveillance and excludes a broader 
definition of costs that might be considered in a more comprehensive evaluation. For 
example, the assessment of resources could include the estimation of indirect costs 
(e.g., follow-up laboratory tests) and costs of secondary data sources (e.g., vital statis­
tics or survey data).
The assessment of the system's operational resources should not be done in isola­
tion of the program or initiative that relies on the public health surveillance system. A 
more formal economic evaluation of the system (i.e., judging costs relative to benefits) 
could be included with the resource description. Estimating the effect of the system on 
decision making, treatment, care, prevention, education, and/or research might be pos­
sible (35,36 ). For some surveillance systems, however, a more realistic approach would 
be to judge costs based on the objectives and usefulness of the system.
Task C. Focus the Evaluation Design
Definition
The direction and process of the evaluation must be focused to ensure that time and 
resources are used as efficiently as possible.
Methods
Focusing the evaluation design for a public health surveillance system involves
• determining the specific purpose of the evaluation (e.g., a change in practice);
• identifying stakeholders (Task A) who will receive the findings and recommen­
dations of the evaluation (i.e., the intended users);
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C ontact p rophylaxis
Personnel 469
Im m une serum  g lobu lin 21
Total $5,616
* Hinds MW, Skaggs JW , Bergeisen GH. Benefit-cost analysis o f active surveillance o f prim ary 
care physicians fo r  hepatitis A. Am  J Public Health 1985;75:176-7.
+ Costs o f trac ing  and p ro v id ing  p rophy lax is  to 38 a dd itiona l active surveillance-associa ted 
contacts o f persons w ith  hepatitis A.
• considering what will be done with the information generated from the evaluation 
(i.e., the intended uses);
• specifying the questions that will be answered by the evaluation; and
• determining standards for assessing the performance of the system.
Discussion
Depending on the specific purpose of the evaluation, its design could be straightfor­
ward or complex. An effective evaluation design is contingent upon a) its specific pur­
pose being understood by all of the stakeholders in the evaluation and b) persons who 
need to know the findings and recommendations of the design being committed to 
using the information generated from it. In addition, when multiple stakeholders are 
involved, agreements that clarify roles and responsibilities might need to be estab­
lished among those who are implementing the evaluation.
Standards for assessing how the public health surveillance system performs estab­
lish what the system must accomplish to be considered successful in meeting its objec­
tives. These standards specify, for example, what levels of usefulness and simplicity 
are relevant for the system, given its objectives. Approaches to setting useful stan­
dards for assessing the system's performance include a review of current scientific 
literature on the health-related event under surveillance and/or consultation with 
appropriate specialists, including users of the data.
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Task D. Gather Credible Evidence Regarding the Performance 
of the Surveillance System
Activities
• Indicate the level of usefulness by describing the actions taken as a result of 
analysis and interpretation of the data from the public health surveillance system. 
Characterize the entities that have used the data to make decisions and take 
actions. List other anticipated uses of the data.
• Describe each of the following system attributes:
—  Simplicity
—  Flexibility
—  Data quality
—  Acceptability
—  Sensitivity





Public health informatics concerns for public health surveillance systems (see Task 
B.2, Discussion) can be addressed in the evidence gathered regarding the performance 
of the system. Evidence of the system's performance must be viewed as credible. For 
example, the gathered evidence must be reliable, valid, and informative for its intended 
use. Many potential sources of evidence regarding the system's performance exist, 
including consultations with physicians, epidemiologists, statisticians, behavioral sci­
entists, public health practitioners, laboratory directors, program managers, data pro­
viders, and data users.
D. 1. Indicate the Level of Usefulness
Definition. A public health surveillance system is useful if it contributes to the pre­
vention and control of adverse health-related events, including an improved under­
standing of the public health implications of such events. A public health surveillance 
system can also be useful if it helps to determine that an adverse health-related event 
previously thought to be unimportant is actually important. In addition, data from a 
surveillance system can be useful in contributing to performance measures (37 ), 
including health indicators (38 ) that are used in needs assessments and accountability 
systems.
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Methods. An assessment of the usefulness of a public health surveillance system 
should begin with a review of the objectives of the system and should consider the 
system's effect on policy decisions and disease-control programs. Depending on the 
objectives of a particular surveillance system, the system might be considered useful if 
it satisfactorily addresses at least one of the following questions. Does the system
• detect diseases, injuries, or adverse or protective exposures of public importance 
in a tim ely way to permit accurate diagnosis or identification, prevention or 
treatment, and handling of contacts when appropriate?
• provide estimates of the magnitude of morbidity and mortality related to the 
health-related event under surveillance, including the identification of factors 
associated with the event?
• detect trends that signal changes in the occurrence of disease, injury, or adverse 
or protective exposure, including detection of epidemics (or outbreaks)?
• permit assessment of the effect of prevention and control programs?
• lead to improved clinical, behavioral, social, policy, or environmental practices? 
or
• stimulate research intended to lead to prevention or control?
A survey of persons who use data from the system might be helpful in gathering 
evidence regarding the usefulness of the system. The survey could be done either for­
mally with standard methodology or informally.
Discussion. Usefulness might be affected by all the attributes of a public health 
surveillance system (see Task D.2, Describe Each System Attribute). For example, 
increased sensitivity might afford a greater opportunity for identifying outbreaks and 
understanding the natural course of an adverse health-related event in the population 
under surveillance. Improved timeliness allows control and prevention activities to be 
initiated earlier. Increased predictive value positive enables public health officials to 
more accurately focus resources for control and prevention measures. A representa­
tive surveillance system will better characterize the epidemiologic characteristics of a 
health-related event in a defined population. Public health surveillance systems that 
are simple, flexible, acceptable, and stable will likely be more complete and useful for 
public health action.
D.2. Describe Each System Attribute 
D.2.a. Simplicity
Definition. The simplicity of a public health surveillance system refers to both its 
structure and ease of operation. Surveillance systems should be as simple as possible 
while still meeting their objectives.
Methods. A chart describing the flow of data and the lines of response in a surveil­
lance system can help assess the simplicity or complexity of a surveillance system. A 
simplified flow chart for a generic surveillance system is included in this report (Figure 1).
The following measures (see Task B.2) might be considered in evaluating the sim­
plicity of a system:
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• amount and type of data necessary to establish that the health-related event has 
occurred (i.e., the case definition has been met);
• amount and type of other data on cases (e.g., demographic, behavioral, and
exposure information for the health-related event);
• number of organizations involved in receiving case reports;
• level of integration with other systems;
• method of collecting the data, including number and types of reporting sources,
and time spent on collecting data;
• amount of follow-up that is necessary to update data on the case;
• method of managing the data, including time spent on transferring, entering, 
editing, storing, and backing up data;
• methods for analyzing and disseminating the data, including time spent on 
preparing the data for dissemination;
• staff training requirements; and
• time spent on maintaining the system.
Discussion. Thinking of the simplicity of a public health surveillance system from 
the design perspective might be useful. An example of a system that is simple in design 
is one with a case definition that is easy to apply (i.e., the case is easily ascertained) and 
in which the person identifying the case will also be the one analyzing and using the 
information. A more complex system might involve some of the following:
• special or follow-up laboratory tests to confirm the case;
• investigation of the case, including telephone contact or a home visit by public 
health personnel to collect detailed information;
• multiple levels of reporting (e.g., with the National Notifiable Diseases 
Surveillance System, case reports might start with the health-care provider who 
makes the diagnosis and pass through county and state health departments 
before going to CDC [29 ]); and
• integration of related systems whereby special training is required to collect and/ 
or interpret data.
Simplicity is closely related to acceptance and timeliness. Simplicity also affects the 
amount of resources required to operate the system.
D.2.b. Flexibility
Definition. A  flexible public health surveillance system can adapt to changing infor­
mation needs or operating conditions with little additional time, personnel, or allocated 
funds. Flexible systems can accommodate, for example, new health-related events, 
changes in case definitions or technology, and variations in funding or reporting 
sources. In addition, systems that use standard data formats (e.g., in electronic data 
interchange) can be easily integrated with other systems and thus might be considered 
flexible.
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Methods. Flexibility is probably best evaluated retrospectively by observing how a 
system has responded to a new demand. An important characteristic of CDC's Behav­
ioral Risk Factor Surveillance System (BRFSS) is its flexibility (39 ). Conducted in col­
laboration with state health departments, BRFSS is an ongoing sample survey that 
gathers and reports state-level prevalence data on health behaviors related to the lead­
ing preventable causes of death as well as data on preventive health practices. The 
system permits states to add questions of their own design to the BRFSS questionnaire 
but is uniform enough to allow state-to-state comparisons for certain questions. These 
state-specific questions can address emergent and locally important health concerns. 
In addition, states can stratify their BRFSS samples to estimate prevalence data for 
regions or counties within their respective states.
Discussion. Unless efforts have been made to adapt the public health surveillance 
system to another disease (or other health-related event), a revised case definition, 
additional data sources, new information technology, or changes in funding, assessing 
the flexibility of that system might be difficult. In the absence of practical experience, 
the design and workings of a system can be examined. Simpler systems might be more 
flexible (i.e., fewer components will need to be modified when adapting the system for 
a change in information needs or operating conditions).
D.2.c. Data Quality
Definition. Data quality reflects the completeness and validity of the data recorded 
in the public health surveillance system.
Methods. Examining the percentage of "unknown" or "blank" responses to items 
on surveillance forms is a straightforward and easy measure of data quality. Data of 
high quality will have low percentages of such responses. However, a full assessment 
of the completeness and validity of the system's data might require a special study. 
Data values recorded in the surveillance system can be compared to "true" values 
through, for example, a review of sampled data (40 ), a special record linkage (41 ), or 
patient interview (42 ). In addition, the calculation of sensitivity (Task D.2.e) and predic­
tive value positive (Task D.2.f) for the system's data fields might be useful in assessing 
data quality.
Quality of data is influenced by the performance of the screening and diagnostic 
tests (i.e., the case definition) for the health-related event, the clarity of hardcopy or 
electronic surveillance forms, the quality of training and supervision of persons who 
complete these surveillance forms, and the care exercised in data management. A 
review of these facets of a public health surveillance system provides an indirect mea­
sure of data quality.
Discussion. Most surveillance systems rely on more than simple case counts. Data 
commonly collected include the demographic characteristics of affected persons, 
details about the health-related event, and the presence or absence of potential risk 
factors. The quality of these data depends on their completeness and validity.
The acceptability (see Task D.2.d) and representativeness (Task D.2.g) of a public 
health surveillance system are related to data quality. With data of high quality, the 
system can be accepted by those who participate in it. In addition, the system can 
accurately represent the health-related event under surveillance.
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D.2.d. Acceptability
Definition. Acceptability reflects the willingness of persons and organizations to 
participate in the surveillance system.
Methods. Acceptability refers to the willingness of persons in the sponsoring agency 
that operates the system and persons outside the sponsoring agency (e.g., persons 
who are asked to report data) to use the system. To assess acceptability, the points of 
interaction between the system and its participants must be considered (Figure 1), 
including persons with the health-related event and those reporting cases.
Quantitative measures of acceptability can include
• subject or agency participation rate (if it is high, how quickly it was achieved);
• interview completion rates and question refusal rates (if the system involves 
interviews);
• completeness of report forms;
• physician, laboratory, or hospital/facility reporting rate; and
• timeliness of data reporting.
Some of these measures might be obtained from a review of surveillance report 
forms, whereas others would require special studies or surveys.
Discussion. Acceptability is a largely subjective attribute that encompasses the w ill­
ingness of persons on whom the public health surveillance system depends to provide 
accurate, consistent, complete, and timely data. Some factors influencing the accept­
ability of a particular system are
• the public health importance of the health-related event;
• acknowledgment by the system of the person's contribution;
• dissemination of aggregate data back to reporting sources and interested parties;
• responsiveness of the system to suggestions or comments;
• burden on time relative to available time;
• ease and cost of data reporting;
• federal and state statutory assurance of privacy and confidentiality;
• the ability of the system to protect privacy and confidentiality;
• federal and state statute requirements for data collection and case reporting; and
• participation from the community in which the system operates.
D.2.e. Sensitivity
Definition. The sensitivity of a surveillance system can be considered on two levels. 
First, at the level of case reporting, sensitivity refers to the proportion of cases of a 
disease (or other health-related event) detected by the surveillance system (43 ). 
Second, sensitivity can refer to the ability to detect outbreaks, including the ability to 
monitor changes in the number of cases over time.
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Methods. The measurement of the sensitivity of a public health surveillance system 
is affected by the likelihood that
• certain diseases or other health-related events are occurring in the population 
under surveillance;
• cases of certain health-related events are under medical care, receive laboratory 
testing, or are otherwise coming to the attention of institutions subject to 
reporting requirements;
• the health-related events w ill be diagnosed/identified, reflecting the skill of health­
care providers and the sensitivity of screening and diagnostic tests (i.e., the case 
definition); and
• the case w ill be reported to the system.
These situations can be extended by analogy to public health surveillance systems 
that do not fit the traditional disease care-provider model. For example, the sensitivity 
of a telephone-based surveillance system of morbidity or risk factors is affected by
• the number of persons who have telephones, who are at home when the call is 
placed, and who agree to participate;
• the ability of persons to understand the questions and correctly identify their 
status; and
• the willingness of respondents to report their status.
The extent to which these situations are explored depends on the system and on the 
resources available for assessing sensitivity. The primary emphasis in assessing sensi­
tiv ity —  assuming that most reported cases are correctly classified —  is to estimate the 
proportion of the total number of cases in the population under surveillance being 
detected by the system, represented by A/(A+C) in this report (Table 3).
Surveillance of vaccine-preventable diseases provides an example of where the 
detection of outbreaks is a critical concern (44 ). Approaches that have been recom­
mended for improving sensitivity of reporting vaccine-preventable diseases might be













* S ensitiv ity  = A/(A+C)
* Predictive value positive (PVP) = A/(A+B)
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applicable to other health-related events (44 ). For example, the sensitivity of a system 
might be improved by
• conducting active surveillance (i.e., contacting all providers and institutions 
responsible for reporting cases);
• using external standards (or other surveillance indicators) to monitor the quality 
of case reporting;
• identifying imported cases;
• tracking the number of cases of suspected disease that are reported, investigated, 
and ruled out as cases;
• monitoring the diagnostic effort (e.g., tracking submission of laboratory requests 
for diagnostic testing); and
• monitoring the circulation of the agent (e.g., virus or bacterium) that causes the 
disease.
The capacity for a public health surveillance system to detect outbreaks (or other 
changes in incidence and prevalence) might be enhanced substantially if detailed diag­
nostic tests are included in the system. For example, the use of molecular subtyping in 
the surveillance of Escherichia coli O157:H7 infections in Minnesota enabled the sur­
veillance system to detect outbreaks that would otherwise have gone unrecognized (45 ).
The measurement of the sensitivity of the surveillance system (Table 3) requires 
a) collection of or access to data usually external to the system to determine the true 
frequency of the condition in the population under surveillance (46 ) and b) validation 
of the data collected by the system. Examples of data sources used to assess the sensi­
tivity of health information or public health surveillance systems include medical records 
(47,48 ) and registries (49,50 ). In addition, sensitivity can be assessed through estima­
tions of the total cases in the population under surveillance by using capture-recapture 
techniques (51,52 ).
To adequately assess the sensitivity of the public health surveillance system, calcu­
lating more than one measurement of the attribute might be necessary. For example, 
sensitivity could be determined for the system's data fields, for each data source or for 
combinations of data sources (48 ), for specific conditions under surveillance (53 ), or 
for each of several years (54 ). The use of a Venn diagram might help depict measure­
ments of sensitivity for combinations of the system's data sources (55 ).
Discussion. A literature review can be helpful in determining sensitivity measure­
ments for a public health surveillance system (56 ). The assessment of the sensitivity of 
each data source, including combinations of data sources, can determine if the elimina­
tion of a current data source or if the addition of a new data source would affect the 
overall surveillance results (48 ).
A public health surveillance system that does not have high sensitivity can still be 
useful in monitoring trends as long as the sensitivity remains reasonably constant over 
time. Questions concerning sensitivity in surveillance systems most commonly arise 
when changes in the occurrence of a health-related event are noted. Changes in sensi­
tiv ity can be precipitated by some circumstances (e.g., heightened awareness of a 
health-related event, introduction of new diagnostic tests, and changes in the method 
of conducting surveillance). A search for such "artifacts" is often an initial step in out­
break investigations.
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D.2.f. Predictive Value Positive
Definition. Predictive value positive (PVP) is the proportion of reported cases that 
actually have the health-related event under surveillance (43 ).
Methods. The assessment of sensitivity and of PVP provide different perspectives 
regarding how well the system is operating. Depending on the objectives of the public 
health surveillance system, assessing PVP whenever sensitivity has been assessed 
might be necessary (47-50,53 ). In this report, PVP is represented by A/(A+B) (Table 3).
In assessing PVP, primary emphasis is placed on the confirmation of cases reported 
through the surveillance system. The effect of PVP on the use of public health resources 
can be considered on two levels. At the level of case detection, PVP affects the amount 
of resources used for case investigations. For example, in some states, every reported 
case of type A hepatitis is promptly investigated by a public health nurse, and contacts 
at risk are referred for prophylactic treatment. A surveillance system with low PVP, and 
therefore frequent "false-positive" case reports, would lead to misdirected resources.
At the level of outbreak (or epidemic) detection, a high rate of erroneous case 
reports might trigger an inappropriate outbreak investigation. Therefore, the propor­
tion of epidemics identified by the surveillance system that are true epidemics can be 
used to assess this attribute.
Calculating the PVP might require that records be kept of investigations prompted 
by information obtained from the public health surveillance system. At the level of case 
detection, a record of the number of case investigations completed and the proportion 
of reported persons who actually had the health-related event under surveillance would 
allow the calculation of the PVP. At the level of outbreak detection, the review of per­
sonnel activity reports, travel records, and telephone logbooks might enable the 
assessment of PVP. For some surveillance systems, however, a review of data external 
to the system (e.g., medical records) might be necessary to confirm cases to calculate 
PVP Examples of data sources used to assess the PVP of health information or public 
health surveillance systems include medical records (48,57 ), registries (49,58 ), and 
death certificates (59 ).
To assess the PVP of the system adequately, calculating more than one measure­
ment of the attribute might be necessary. For example, PVP could be determined for 
the system's data fields, for each data source or combinations of data sources (48 ), or 
for specific health-related events (49 ).
Discussion. PVP is important because a low value means that noncases might be 
investigated, and outbreaks might be identified that are not true but are instead arti­
facts of the public health surveillance system (e.g., a "pseudo-outbreak"). False-positive 
reports can lead to unnecessary interventions, and falsely detected outbreaks can lead 
to costly investigations and undue concern in the population under surveillance. A 
public health surveillance system with a high PVP will lead to fewer misdirected resources.
The PVP reflects the sensitivity and specificity of the case definition (i.e., the screen­
ing and diagnostic tests for the health-related event) and the prevalence of the health- 
related event in the population under surveillance. The PVP can improve with increasing 
specificity of the case definition. In addition, good communication between the per­
sons who report cases and the receiving agency can lead to an improved PVP.
D.2.g. Representativeness
Definition. A public health surveillance system that is representative accurately 
describes the occurrence of a health-related event over time and its distribution in the 
population by place and person.
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Methods. Representativeness is assessed by comparing the characteristics of 
reported events to all such actual events. Although the latter information is generally 
not known, some judgment of the representativeness of surveillance data is possible, 
based on knowledge of
• characteristics of the population, including, age, socioeconomic status, access to 
health care, and geographic location (60 );
• clinical course of the disease or other health-related event (e.g., latency period, 
mode of transmission, and outcome [e.g., death, hospitalization, or disability]);
• prevailing medical practices (e.g., sites performing diagnostic tests and 
physician-referral patterns) (33,61 ); and
• multiple sources of data (e.g., mortality rates for comparison with incidence data 
and laboratory reports for comparison with physician reports).
Representativeness can be examined through special studies that seek to identify a 
sample of all cases. For example, the representativeness of a regional injury surveil­
lance system was examined using a systematic sample of injured persons (62 ). The 
study examined statistical measures of population variables (e.g., age, sex, residence, 
nature of injury, and hospital admission) and concluded that the differences in the dis­
tribution of injuries in the system's database and their distribution in the sampled data 
should not affect the ability of the surveillance system to achieve its objectives.
For many health-related events under surveillance, the proper analysis and inter­
pretation of the data require the calculation of rates. The denominators for these rate 
calculations are often obtained from a completely separate data system maintained by 
another agency (e.g., the United States Bureau of the Census in collaboration with state 
governments [63 ]). The choice of an appropriate denominator for the rate calculation 
should be given careful consideration to ensure an accurate representation of the health- 
related event over time and by place and person. For example, numerators and 
denominators must be comparable across categories (e.g., race [64 ], age, residence, 
and/or time period), and the source for the denominator should be consistent over time 
when measuring trends in rates. In addition, consideration should be given to the 
selection of the standard population for the adjustment of rates (65 ).
Discussion. To generalize findings from surveillance data to the population at large, 
the data from a public health surveillance system should accurately reflect the charac­
teristics of the health-related event under surveillance. These characteristics generally 
relate to time, place, and person. An important result of evaluating the representative­
ness of a surveillance system is the identification of population subgroups that might 
be systematically excluded from the reporting system through inadequate methods of 
monitoring them. This evaluation process enables appropriate modification of data 
collection procedures and more accurate projection of incidence of the health-related 
event in the target population (66 ).
For certain health-related events, the accurate description of the event over time 
involves targeting appropriate points in a broad spectrum of exposure and the result­
ant disease or condition. In the surveillance of cardiovascular diseases, for example, it 
might be useful to distinguish between preexposure conditions (e.g., tobacco use poli­
cies and social norms), the exposure (e.g., tobacco use, diet, exercise, stress, and 
genetics), a pre-symptomatic phase (e.g., cholesterol and homocysteine levels), early- 
staged disease (e.g., abnormal stress test), late-staged disease (e.g., angina and acute
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myocardial infarction), and death from the disease. The measurement of risk factor 
behaviors (e.g., tobacco use) might enable the monitoring of important aspects in the 
development of a disease or other health-related event.
Because surveillance data are used to identify groups at high risk and to target and 
evaluate interventions, being aware of the strengths and limitations of the system's 
data is important. Errors and bias can be introduced into the system at any stage (67 ). 
For example, case ascertainment (or selection) bias can result from changes in report­
ing practices over time or from differences in reporting practices by geographic loca­
tion or by health-care providers. Differential reporting among population subgroups 
can result in misleading conclusions about the health-related event under surveillance.
D.2.h. Timeliness
Definition. Timeliness reflects the speed between steps in a public health surveil­
lance system.
Methods. A  simplified example of the steps in a public health surveillance system is 
included in this report (Figure 2). The time interval linking any two of these steps can be 
examined. The interval usually considered first is the amount of time between the 
onset of a health-related event and the reporting of that event to the public health 
agency responsible for instituting control and prevention measures. Factors affecting 
the time involved during this interval can include the patient's recognition of symp­
toms, the patient's acquisition of medical care, the attending physician's diagnosis or
FIGURE 2. Simplified example of steps in a surveillance system
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submission of a laboratory test, the laboratory reporting test results back to the physi­
cian and/or to a public health agency, and the physician reporting the event to a public 
health agency. Another aspect of timeliness is the time required for the identification of 
trends, outbreaks, or the effect of control and prevention measures. Factors that influ­
ence the identification process can include the severity and communicability of the 
health-related event, staffing of the responsible public health agency, and communica­
tion among involved health agencies and organizations. The most relevant time inter­
val might vary with the type of health-related event under surveillance. With acute or 
infectious diseases, for example, the interval from the onset of symptoms or the date of 
exposure might be used. With chronic diseases, it might be more useful to look at 
elapsed time from diagnosis rather than from the date of symptom onset.
Discussion. The timeliness of a public health surveillance system should be evalu­
ated in terms of availability of information for control of a health-related event, includ­
ing immediate control efforts, prevention of continued exposure, or program planning. 
The need for rapidity of response in a surveillance system depends on the nature of the 
health-related event under surveillance and the objectives of that system. A study of a 
public health surveillance system for Shigella infections, for example, indicated that 
the typical case of shigellosis was brought to the attention of health officials 11 days 
after onset of symptoms —  a period sufficient for the occurrence of secondary and 
tertiary transmission. This example indicates that the level of timeliness was not satis­
factory for effective disease control (68 ). However, when a long period of latency 
occurs between exposure and appearance of disease, the rapid identification of cases 
of illness might not be as important as the rapid availability of exposure data to provide 
a basis for interrupting and preventing exposures that lead to disease. For example, 
children with elevated blood lead levels and no clinically apparent illness are at risk for 
adverse health-related events. CDC recommends that follow-up of asymptomatic chil­
dren with elevated blood lead levels include educational activities regarding lead poi­
soning prevention and investigation and remediation of sources of lead exposure (69 ). 
In addition, surveillance data are being used by public health agencies to track progress 
toward national and state health objectives (38,70 ).
The increasing use of electronic data collection from reporting sources (e.g., an elec­
tronic laboratory-based surveillance system) and via the Internet (a web-based sys­
tem), as well as the increasing use of electronic data interchange by surveillance 
systems, might promote timeliness (6,29,71,72 ).
D.2.i. Stability
Definition. Stability refers to the reliability (i.e., the ability to collect, manage, and 
provide data properly without failure) and availability (the ability to be operational when 
it is needed) of the public health surveillance system.
Methods. Measures of the system's stability can include
• the number of unscheduled outages and down times for the system's computer;
• the costs involved with any repair of the system's computer, including parts, 
service, and amount of time required for the repair;
• the percentage of time the system is operating fully;
• the desired and actual amount of time required for the system to collect or receive 
data;
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• the desired and actual amount of time required for the system to manage the data, 
including transfer, entry, editing, storage, and back-up of data; and
• the desired and actual amount of time required for the system to release data.
Discussion. A  lack of dedicated resources might affect the stability of a public health 
surveillance system. For example, workforce shortages can threaten reliability and avail­
ability. Yet, regardless of the health-related event being monitored, a stable perfor­
mance is crucial to the viability of the surveillance system. Unreliable and unavailable 
surveillance systems can delay or prevent necessary public health action.
A more formal assessment of the system's stability could be made through model­
ing procedures (73 ). However, a more useful approach might involve assessing stabil­
ity based on the purpose and objectives of the system.
Task E. Justify and State Conclusions, and Make 
Recommendations
Conclusions from the evaluation can be justified through appropriate analysis, syn­
thesis, interpretation, and judgement of the gathered evidence regarding the perfor­
mance of the public health surveillance system (Task D). Because the stakeholders (Task A) 
must agree that the conclusions are justified before they will use findings from the 
evaluation with confidence, the gathered evidence should be linked to their relevant 
standards for assessing the system's performance (Task C). In addition, the conclusions 
should state whether the surveillance system is addressing an important public health 
problem (Task B.1) and is meeting its objectives (Task B.2).
Recommendations should address the modification and/or continuation of the pub­
lic health surveillance system. Before recommending modifications to a system, the 
evaluation should consider the interdependence of the system's costs (Task B.3) and 
attributes (Task D.2). Strengthening one system attribute could adversely affect 
another attribute of a higher priority. Efforts to improve sensitivity, PVP, representative­
ness, timeliness, and stability can increase the cost of a surveillance system, although 
savings in efficiency with computer technology (e.g., electronic reporting) might offset 
some of these costs. As sensitivity and PVP approach 100%, a surveillance system is 
more likely to be representative of the population with the event under surveillance. 
However, as sensitivity increases, PVP might decrease. Efforts to increase sensitivity 
and PVP might increase the complexity of a surveillance system —  potentially decreas­
ing its acceptability, timeliness, and flexibility. In a study comparing health-department- 
initiated (active) surveillance and provider-initiated (passive) surveillance, for example, 
the active surveillance did not improve timeliness, despite increased sensitivity (61 ). In 
addition, the recommendations can address concerns about ethical obligations in 
operating the system (74 ).
In some instances, conclusions from the evaluation indicate that the most appropri­
ate recommendation is to discontinue the public health surveillance system; however, 
this type of recommendation should be considered carefully before it is issued. The 
cost of renewing a system that has been discontinued could be substantially greater 
than the cost of maintaining it. The stakeholders in the evaluation should consider 
relevant public health and other consequences of discontinuing a surveillance system.
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Task F. Ensure Use of Evaluation Findings and Share 
Lessons Learned
Deliberate effort is needed to ensure that the findings from a public health surveil­
lance system evaluation are used and disseminated appropriately. When the evalua­
tion design is focused (Task C), the stakeholders (Task A) can comment on decisions 
that might affect the likelihood of gathering credible evidence regarding the system's 
performance. During the implementation of the evaluation (Tasks D and E), considering 
how potential findings (particularly negative findings) could affect decisions made about 
the surveillance system might be necessary. When conclusions from the evaluation 
and recommendations are made (Task E), follow-up might be necessary to remind 
intended users of their planned uses and to prevent lessons learned from becoming 
lost or ignored.
Strategies for communicating the findings from the evaluation and recommenda­
tions should be tailored to relevant audiences, including persons who provided data 
used for the evaluation. In the public health community, for example, a formal written 
report or oral presentation might be important but not necessarily the only means of 
communicating findings and recommendations from the evaluation to relevant audi­
ences. Several examples of formal written reports of surveillance evaluations have 
been included in peer-reviewed journals (51,53,57,59,75 ).
SUMMARY
The guidelines in this report address evaluations of public health surveillance 
systems. However, these guidelines could also be applied to several systems, including 
health information systems used for public health action, surveillance systems that are 
pilot tested, and information systems at individual hospitals or health-care centers. 
Additional information can also be useful for planning, establishing, as well as effi­
ciently and effectively monitoring a public health surveillance system (6-7 ).
To promote the best use of public health resources, all public health surveillance 
systems should be evaluated periodically. No perfect system exists; however, and 
trade-offs must always be made. Each system is unique and must balance benefit ver­
sus personnel, resources, and cost allocated to each of its components if the system is 
to achieve its intended purpose and objectives.
The appropriate evaluation of public health surveillance systems becomes para­
mount as these systems adapt to revised case definitions, new health-related events, 
new information technology (including standards for data collection and sharing), cur­
rent requirements for protecting patient privacy, data confidentiality, and system secu­
rity. The goal of this report has been to make the evaluation process inclusive, explicit, 
and objective. Yet, this report has presented guidelines —  not absolutes —  for the evalu­
ation of public health surveillance systems. Progress in surveillance theory, technol­
ogy, and practice continues to occur, and guidelines for evaluating a surveillance system 
will necessarily evolve.
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Tasks for evaluating a surveillance system* Page(s) in this report
Task A. Engage the stakeholders in the evaluation 4
Task B. Describe the surveillance system to be evaluated 4-11
1. Describe the public health importance of the health-related event under surveillance 4- 5
a. Indices of frequency
b. Indices of severity
c. Disparities or inequities associated with the health-related event
d. Costs associated with the health-related event
e. Preventability
f. Potential future clinical course in the absence of an intervention
g. Public interest
2. Describe the purpose and operation of the surveillance system 5-10
a. Purpose and objectives of the system
b. Planned uses of the data from the system
c. Health-related event under surveillance, including case definition
d. Legal authority for data collection
e. The system resides where in organization(s)
f. Level of integration with other system s, if appropriate
g. Flow  chart of system
h. Components of system
1) Population under surveillance
2) Period of time of data collection
3) Data collection
4) Reporting sources of data
5) Data management
6) Data analysis and dissemination
7) Patient privacy, data confidentiality, and system security
8) Records management program




Task C. Focus the evaluation design 11-12
1. Determine the specific purpose of the evaluation
2. Identify stakeholders who will receive the findings and recommendations of the evaluation
3. Consider what will be done with the information generated from the evaluation
4. Specify the questions that will be answered by the evaluation
5. Determine standards for assessing the performance of the system
Task D. Gather credible evidence regarding the performance of the surveillance system 13-24
1. Indicate the level of usefulness 13-14










Task E. Justify  and state conclusions, and make recommendations 24
Task F. Ensure use of evaluation findings and share lessons learned 25
* Adapted from Fram ew ork fo r Program  Evaluation in Public Health [CDC. Framework for program evaluation in 
public health. MMWR 1999;48(RR-11)] and the original guidelines [CDC. Guidelines for evaluating surveillance 
systems. MMWR 1988;37(No. S-5)].
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Appendix B.
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system* Relevant standards1
Task A . Engage the stakeholders 
in the evaluation.
Task B. Describe the surveillance system 
to be evaluated.
Task C. Focus the evaluation design.
Stakeholder identification. Persons involved in or 
affected by the evaluation should be identified so that 
their needs can be addressed.
Evaluator credibility. The persons conducting the 
evaluation should be trustworthy and competent in 
performing the evaluation to ensure that findings from 
the evaluation achieve maximum credibility and 
acceptance.
Formal agreements. If applicable, all principal 
parties involved in an evaluation should agree in 
writing to their obligations (i.e., what is to be done, 
how, by whom, and when) so that each party must 
adhere to the conditions of the agreement or 
renegotiate them.
Rights of human subjects. The evaluation should 
be designed and conducted in a manner that respects 
and protects the rights and welfare of human subjects. 
Fluman interactions. Evaluators should interact 
respectfully with other persons associated with an 
evaluation so that participants are not threatened or 
harmed.
Conflict of interest. Conflict of interest should be 
handled openly and honestly so that the evaluation 
processes and results are not compromised. 
Metaevaluation. The evaluation should be forma­
tively and summatively evaluated against these and 
other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
stakeholders.
Complete and fair assessment. The evaluation 
should be complete and fair in its examination and 
recording of strengths and weaknesses of the system 
so that strengths can be enhanced and problem areas 
addressed.
System documentation. The system being 
evaluated should be documented clearly and 
accurately.
Context analysis. The context in which the system 
exists should be examined in enough detail to identify 
probable influences on the system.
Metaevaluation. The evaluation should be 
formatively and summatively evaluated against these 
and other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
stakeholders.
Evaluation impact. Evaluations should be planned, 
conducted, and reported in ways that encourage 
follow-through by stakeholders to increase the 
likelihood of the evaluation being used.
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Cross-reference of Tasks and Relevant Standards
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Tasks for evaluating a surveillance system*
Task C. (C ontinued  ) Focus the evaluation design.
Task D. Gather credible evidence 
regarding the performance of the 
surveillance system.
Relevant standards1
Practical procedures. Evaluation procedures should 
be practical while needed information is being 
obtained to keep disruptions to a minimum.
Political viability. During the planning and 
conducting of the evaluation, consideration should be 
given to the varied positions of interest groups so that 
their cooperation can be obtained and possible 
attempts by any group to curtail evaluation operations 
or to bias or misapply the results can be averted or 
counteracted.
Cost-effectiveness. The evaluation should be 
efficient and produce valuable information to justify 
expended resources.
Service orientation. The evaluation should be 
designed to assist organizations in addressing and 
serving effectively the needs of the targeted 
participants.
Complete and fair assessment. The evaluation 
should be complete and fair in its examination and 
recording of strengths and weaknesses of the system 
so that strengths can be enhanced and problem areas 
addressed.
Fiscal responsibility. The evaluator's allocation and 
expenditure of resources should reflect sound 
accountability procedures by being prudent and 
ethically responsible so that expenditures are 
accountable and appropriate.
Described purpose and procedures. The purpose 
and procedures of the evaluation should be monitored 
and described in enough detail to identify and assess 
them. The purpose of evaluating a surveillance 
system is to promote the best use of public health 
resources by ensuring that only important problems 
are under surveillance and that surveillance systems 
operate efficiently.
Metaevaluation. The evaluation should be 
formatively and summatively evaluated against these 
and other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
stakeholders.
Information scope and selection. Information 
collected should address pertinent questions 
regarding the system and be responsive to the needs 
and interests of clients and other specified 
stakeholders.
Defensible information sources. Sources of 
information used in the system evaluation should be 
described in enough detail to assess the adequacy of 
the information.
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Appendix B. — Continued
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system*
Task D. (C ontinued  ) Gather credible evidence 
regarding the performance of the 
surveillance system.
Task E. Justify  and state conclusions, 
and make recommendations.
Task F. Ensure use of evaluation findings 
and share lessons learned.
Relevant standards1
Valid information. Information-gathering 
procedures should be developed and implemented to 
ensure a valid interpretation for the intended use. 
Reliable information. Information-gathering 
procedures should be developed and implemented to 
ensure sufficiently reliable information for the 
intended use.
Systematic information. Information collected, 
processed, and reported in an evaluation should be 
system atically reviewed and any errors corrected. 
Metaevaluation. The evaluation should be 
formatively and summatively evaluated against these 
and other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
stakeholders.
Values identification. The perspectives, procedures, 
and rationale used to interpret the findings should be 
carefully described so that the bases for value 
judgments are clear.
Analysis of information. Information should be 
analyzed appropriately and system atically so that 
evaluation questions are answered effectively. 
Justified conclusions. Conclusions that are reached 
should be explicitly justified for stakeholders' 
assessment.
Metaevaluation. The evaluation should be 
formatively and summatively evaluated against these 
and other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
stakeholders.
Evaluator credibility. The persons conducting the 
evaluation should be trustworthy and competent in 
performing the evaluation to ensure that findings from 
the evaluation achieve maximum credibility and 
acceptance.
Report clarity. Evaluation reports should clearly 
describe the system being evaluated, including its 
context and the purposes, procedures, and findings of 
the evaluation so that essential information is provided 
and easily understood.
Report timeliness and dissemination. Substantial 
interim findings and evaluation reports should be 
disseminated to intended users so that they can be 
used in a tim ely fashion.
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Tasks for evaluating a surveillance system* Relevant standards1
Task F. Ensure use of the findings of the evaluation Evaluation impact. Evaluations should be planned,
and share lessons learned. conducted, and reported in ways that encourage
follow-through by stakeholders to increase the 
likelihood of the evaluation being used.
Disclosure of findings. The principal parties of an 
evaluation should ensure that the full evaluation 
findings with pertinent limitations are made accessible 
to the persons affected by the evaluation and any 
others with expressed legal rights to receive the 
results.
Impartial reporting. Reporting procedures should 
guard against the distortion caused by personal 
feelings and biases of any party involved in the 
evaluation so that the evaluation reflects the findings 
fairly.
Metaevaluation. The evaluation should be 
formatively and summatively evaluated against these 
and other pertinent standards to guide its conduct 
appropriately and, on completion, to enable close 
examination of its strengths and weaknesses by 
_________________________________________________________________stakeholders.__________________________________________________
* Adapted from Fram ew ork fo r Program  Evaluation in  Public Health [CDC. Framework for program evaluation in 
public health. MMWR 1999;48(RR—11)] and the original guidelines [CDC. Guidelines for evaluating surveillance 
systems. MMWR 1988;37(No. S-5)].
* Adapted from Fram ew ork fo r Program  Evaluation in  Public Health [CDC. Framework for program evaluation in 
public health. MMWR 1999;48(RR-11)].
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